vs 6,526 other HR bills in the 114th — cohort avg 56d
Summary
Protecting Seniors' Access to Medicare Act of 2015 (Sec. 2) Repeals sections of the Patient Protection and Affordable Care Act (and restores provisions of law amended by those sections) related to the establishment of an Independent Payment Advisory Board to develop proposals to reduce the per capita rate of growth in spending under title XVIII (Medicare) of the Social Security Act. (Sec. 3) Rescinds specified appropriations to the Prevention and Public Health Fund for FY2017-FY2026 and each fiscal year thereafter.
Lobbying filings that explicitly cite this bill (50)
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Received in the Senate and Read twice and referred to the Committee on Finance.
June 23, 2015
Motion to reconsider laid on the table Agreed to without objection.
June 23, 2015
On passage Passed by the Yeas and Nays: 244 - 154 (Roll no. 376).
House
June 23, 2015
Passed/agreed to in House: On passage Passed by the Yeas and Nays: 244 - 154 (Roll no. 376).
House
June 23, 2015
Considered as unfinished business. (consideration: CR H4579-4580)
June 18, 2015
POSTPONED PROCEEDINGS - The Chair put the question on passage of H.R. 1190 and by voice vote, announced that the ayes had prevailed. Mr. Pitts demanded the yeas and nays which were ordered, and pursuant to clause 8, rule XX, the Chair postponed further proceedings on the question of passage of H.R. 1190 until a time to be announced.
June 18, 2015
The previous question was ordered pursuant to the rule. (consideration: CR H4535)
June 18, 2015
DEBATE - Pursuant to the provisions of H. Res. 319, the amendment printed in part B of the report of the Committee on Rules accompanying this resolution shall be considered as adopted. The House proceeded with one hour of debate on H.R. 1190.
Cited source text, amounts, lobbyists, and targets
RetireSafe worked as a leader, along with other patient advocate groups, to oppose any new cuts to the Medicare Advantage payment rates for 2016.
RetireSafe worked with the Medicare Access for Patients Rx Coalition (MAPRx) to raise concerns regarding the Advance Notice of Methodological Changes for Calendar Year 2016 for Medicare Advantage Capitation Rates, Part C and Part D Payment Policies and 2016 Call Letter to express concerns related to: the Exceptions and Appeals Process, Star Ratings and the Dual-Eligibles, Formulary Oversight, Drug Utilization Review Controls, Tier Labeling and Composition, Specialty Tiers, and the Use of Multiple Tiers with Coinsurance Cost-Sharing Rates.
RetireSafe joined with the Medicare Rights Center and other patient advocates to urge numerous changes to the Medicare Part D Program to make the Exceptions and Appeals Processes More Accessible for Beneficiaries.
RetireSafe joined with the Healthcare Leadership Council and others to support the Protecting Seniors Access to Medicare Act, (H.R. 1190 and S. 141) to repeal the Independent Payment Advisory Board (IPAB), authorized under the Patient Protection and Affordable Care Act.
Support H.R. 2624 and S. 1488, the Part D Beneficiary Appeals Fairness Act.
Support the passage of H.R. 160 to repeal the 2.3% Medical Device Tax.
Support the passage of H.R. 1190 to repeal the Independent Payment Advisory Board (IPAB).
Joined with the MAPRx coalition to urge Congress to build on the success of Medicare Part D to ensure robust formularies, coverage for the six-protected classes, strong oversight, and transparency for consumers, as well as add improvements to the process for notice of non-coverage, appeals and exceptions.
Also, urged Part D remedies to correct gaps in coverage, onerous cost-shifting created by specialty tiers, and restrictive utilization management tools that severely reduce patient benefits.
Support "340B" Medicaid program reform to end widespread abuse of the drug discount program that ultimately harms patients.
Joined with other patient advocate groups to comment on proposed rule: CMS-2390-P-Medicaid and Childrens Health Insurance Programs (CHIP); Medicaid Managed Care, CHIP Delivered in Managed Care, Medicaid and CHIP Comprehensive Quality Strategies, and Revisions Related to Third Party Liability. We supported the proposed rules intent to strengthen program integrity safeguards, and ensure beneficiary protections in areas of provider networks, coverage standards, and the treatment of appeals. We agree with the other groups that a modernized Medicaid managed care regulatory structure is essential to facilitate necessary system reform initiatives, and advance the delivery of health care for millions of people, and we supported rule changes to achieve those goals.
RetireSafe joined with other patient advocates to comment on proposed rule: CMS-1631-P-Medicare Program; Revisions to Payment Policies under the Physician Fee Schedule and Other Revisions to Part B for CY2016. In commenting we supported various measures for improving accuracy for primary care and care management services; providing appropriate advanced care planning services; providing better Medicare Tele-health services; providing better Chronic Care Management services for Rural Health Clinics and Qualified Health Centers; providing a useful Physicians Compare Website with data in proper context; and providing physician payment, efficiency, and quality improvements linked to a physician quality reporting system.
RetireSafe joined with numerous patient groups to oppose a new CMS plan to cut the payment rate (from Average Sales Price plus 6%) for Medicare Part B Drugs administered by physicians in large parts of the U.S. because this Center for Medicare & Medicaid initiative focuses on costs rather than patients needs and health care quality. This new Part B Drug Plan will adversely impact Medicare patients with complex conditions such as cancer, macular degeneration, hypertension, rheumatoid arthritis, and primary immunodeficiency diseases.
Along with many other patient advocates in the MAPRx Coalition, we strongly opposed a recent MedPAC effort to place Medicare cost savings ahead of the best interests of Medicare patients. Specifically, we urged MedPAC to reject proposals to make changes to true out-of-pocket costs (TrOOP); increase copays for low-income subsidy (LIS) beneficiaries; and eliminate any of the protected classes.
RetireSafe joined with numerous patient groups to comment on the CMS Advance Notice and Draft Call Letter issued on February 19, 2016. The comments focused on better patient access to Medicare Part D Prescription Drugs and related specifically to: Specialty Tier Thresholds, Tier Labeling and Composition, Generic Tier $0 Copay Plans, Formulary Oversight, Drug Utilization Review Controls, Coverage Determination Timelines, and Access to Preferred Cost-sharing Pharmacies.
RetireSafe has continued to work with a large number of patient groups (on several occasions) to strongly oppose the Centers for Medicare Services (CMS) Centers for Medicare and Medicaid Innovation (CMMI) March 8, 2016 proposed rule that would implement substantial changes to the Medicare Part B payment program. As we have stated in several joint letters to Members of Congress and to CMS, we believe the proposed changes which have been proposed as a demonstration project would impact some 75 percent of Medicare population and could limit access to the full range of available treatments under Part B to treat serious illnesses and medical treatments such as cancer, multiple sclerosis, primary immune deficiency, macular degeneration and schizophrenia. Unfortunately, the proposed program will be, in fact, mandatory for many physicians and their patients, and will cause patients to switch from the most appropriate treatment to less effective therapies or to forego treatment altogether because of transportation hurdles created by the new rule. RetireSafe also objects to the lack of sufficient stakeholder input from the beginning of this rule-making process, which has now created one-size-fits-all government payment policies that ignore patient differences and completely undermines the goal of patient-centered Medicare.
Client expense: $11,560 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
RetireSafe worked as a leader, along with other patient advocate groups, to oppose any new cuts to the Medicare Advantage payment rates for 2016.
RetireSafe worked with the Medicare Access for Patients Rx Coalition (MAPRx) to raise concerns regarding the Advance Notice of Methodological Changes for Calendar Year 2016 for Medicare Advantage Capitation Rates, Part C and Part D Payment Policies and 2016 Call Letter to express concerns related to: the Exceptions and Appeals Process, Star Ratings and the Dual-Eligibles, Formulary Oversight, Drug Utilization Review Controls, Tier Labeling and Composition, Specialty Tiers, and the Use of Multiple Tiers with Coinsurance Cost-Sharing Rates.
RetireSafe joined with the Medicare Rights Center and other patient advocates to urge numerous changes to the Medicare Part D Program to make the Exceptions and Appeals Processes More Accessible for Beneficiaries.
RetireSafe joined with the Healthcare Leadership Council and others to support the Protecting Seniors Access to Medicare Act, (H.R. 1190 and S. 141) to repeal the Independent Payment Advisory Board (IPAB), authorized under the Patient Protection and Affordable Care Act.
Support H.R. 2624 and S. 1488, the Part D Beneficiary Appeals Fairness Act.
Support the passage of H.R. 160 to repeal the 2.3% Medical Device Tax.
Support the passage of H.R. 1190 to repeal the Independent Payment Advisory Board (IPAB).
Joined with the MAPRx coalition to urge Congress to build on the success of Medicare Part D to ensure robust formularies, coverage for the six-protected classes, strong oversight, and transparency for consumers, as well as add improvements to the process for notice of non-coverage, appeals and exceptions.
Also, urged Part D remedies to correct gaps in coverage, onerous cost-shifting created by specialty tiers, and restrictive utilization management tools that severely reduce patient benefits.
Support "340B" Medicaid program reform to end widespread abuse of the drug discount program that ultimately harms patients.
Joined with other patient advocate groups to comment on proposed rule: CMS-2390-P-Medicaid and Childrens Health Insurance Programs (CHIP); Medicaid Managed Care, CHIP Delivered in Managed Care, Medicaid and CHIP Comprehensive Quality Strategies, and Revisions Related to Third Party Liability. We supported the proposed rules intent to strengthen program integrity safeguards, and ensure beneficiary protections in areas of provider networks, coverage standards, and the treatment of appeals. We agree with the other groups that a modernized Medicaid managed care regulatory structure is essential to facilitate necessary system reform initiatives, and advance the delivery of health care for millions of people, and we supported rule changes to achieve those goals.
RetireSafe joined with other patient advocates to comment on proposed rule: CMS-1631-P-Medicare Program; Revisions to Payment Policies under the Physician Fee Schedule and Other Revisions to Part B for CY2016. In commenting we supported various measures for improving accuracy for primary care and care management services; providing appropriate advanced care planning services; providing better Medicare Tele-health services; providing better Chronic Care Management services for Rural Health Clinics and Qualified Health Centers; providing a useful Physicians Compare Website with data in proper context; and providing physician payment, efficiency, and quality improvements linked to a physician quality reporting system.
RetireSafe joined with numerous patient groups to oppose a new CMS plan to cut the payment rate (from Average Sales Price plus 6%) for Medicare Part B Drugs administered by physicians in large parts of the U.S. because this Center for Medicare & Medicaid initiative focuses on costs rather than patients needs and health care quality. This new Part B Drug Plan will adversely impact Medicare patients with complex conditions such as cancer, macular degeneration, hypertension, rheumatoid arthritis, and primary immunodeficiency diseases.
Along with many other patient advocates in the MAPRx Coalition, we strongly opposed a recent MedPAC effort to place Medicare cost savings ahead of the best interests of Medicare patients. Specifically, we urged MedPAC to reject proposals to make changes to true out-of-pocket costs (TrOOP); increase copays for low-income subsidy (LIS) beneficiaries; and eliminate any of the protected classes.
RetireSafe joined with numerous patient groups to comment on the CMS Advance Notice and Draft Call Letter issued on February 19, 2016. The comments focused on better patient access to Medicare Part D Prescription Drugs and related specifically to: Specialty Tier Thresholds, Tier Labeling and Composition, Generic Tier $0 Copay Plans, Formulary Oversight, Drug Utilization Review Controls, Coverage Determination Timelines, and Access to Preferred Cost-sharing Pharmacies.
RetireSafe has continued to work with a large number of patient groups (on several occasions) to strongly oppose the Centers for Medicare Services (CMS) Centers for Medicare and Medicaid Innovation (CMMI) March 8, 2016 proposed rule that would implement substantial changes to the Medicare Part B payment program. As we have stated in several joint letters to Members of Congress and to CMS, we believe the proposed changes which have been proposed as a demonstration project would impact some 75 percent of Medicare population and could limit access to the full range of available treatments under Part B to treat serious illnesses and medical treatments such as cancer, multiple sclerosis, primary immune deficiency, macular degeneration and schizophrenia. Unfortunately, the proposed program will be, in fact, mandatory for many physicians and their patients, and will cause patients to switch from the most appropriate treatment to less effective therapies or to forego treatment altogether because of transportation hurdles created by the new rule. RetireSafe also objects to the lack of sufficient stakeholder input from the beginning of this rule-making process, which has now created one-size-fits-all government payment policies that ignore patient differences and completely undermines the goal of patient-centered Medicare.
Cited source text, amounts, lobbyists, and targets
RetireSafe worked as a leader, along with other patient advocate groups, to oppose any new cuts to the Medicare Advantage payment rates for 2016.
RetireSafe worked with the Medicare Access for Patients Rx Coalition (MAPRx) to raise concerns regarding the Advance Notice of Methodological Changes for Calendar Year 2016 for Medicare Advantage Capitation Rates, Part C and Part D Payment Policies and 2016 Call Letter to express concerns related to: the Exceptions and Appeals Process, Star Ratings and the Dual-Eligibles, Formulary Oversight, Drug Utilization Review Controls, Tier Labeling and Composition, Specialty Tiers, and the Use of Multiple Tiers with Coinsurance Cost-Sharing Rates.
RetireSafe joined with the Medicare Rights Center and other patient advocates to urge numerous changes to the Medicare Part D Program to make the Exceptions and Appeals Processes More Accessible for Beneficiaries.
RetireSafe joined with the Healthcare Leadership Council and others to support the Protecting Seniors Access to Medicare Act, (H.R. 1190 and S. 141) to repeal the Independent Payment Advisory Board (IPAB), authorized under the Patient Protection and Affordable Care Act.
Support H.R. 2624 and S. 1488, the Part D Beneficiary Appeals Fairness Act.
Support the passage of H.R. 160 to repeal the 2.3% Medical Device Tax.
Support the passage of H.R. 1190 to repeal the Independent Payment Advisory Board (IPAB).
Joined with the MAPRx coalition to urge Congress to build on the success of Medicare Part D to ensure robust formularies, coverage for the six-protected classes, strong oversight, and transparency for consumers, as well as add improvements to the process for notice of non-coverage, appeals and exceptions.
Also, urged Part D remedies to correct gaps in coverage, onerous cost-shifting created by specialty tiers, and restrictive utilization management tools that severely reduce patient benefits.
Support "340B" Medicaid program reform to end widespread abuse of the drug discount program that ultimately harms patients.
Joined with other patient advocate groups to comment on proposed rule: CMS-2390-P-Medicaid and Childrens Health Insurance Programs (CHIP); Medicaid Managed Care, CHIP Delivered in Managed Care, Medicaid and CHIP Comprehensive Quality Strategies, and Revisions Related to Third Party Liability. We supported the proposed rules intent to strengthen program integrity safeguards, and ensure beneficiary protections in areas of provider networks, coverage standards, and the treatment of appeals. We agree with the other groups that a modernized Medicaid managed care regulatory structure is essential to facilitate necessary system reform initiatives, and advance the delivery of health care for millions of people, and we supported rule changes to achieve those goals.
RetireSafe joined with other patient advocates to comment on proposed rule: CMS-1631-P-Medicare Program; Revisions to Payment Policies under the Physician Fee Schedule and Other Revisions to Part B for CY2016. In commenting we supported various measures for improving accuracy for primary care and care management services; providing appropriate advanced care planning services; providing better Medicare Tele-health services; providing better Chronic Care Management services for Rural Health Clinics and Qualified Health Centers; providing a useful Physicians Compare Website with data in proper context; and providing physician payment, efficiency, and quality improvements linked to a physician quality reporting system.
RetireSafe joined with numerous patient groups to oppose a new CMS plan to cut the payment rate (from Average Sales Price plus 6%) for Medicare Part B Drugs administered by physicians in large parts of the U.S. because this Center for Medicare & Medicaid initiative focuses on costs rather than patients needs and health care quality. This new Part B Drug Plan will adversely impact Medicare patients with complex conditions such as cancer, macular degeneration, hypertension, rheumatoid arthritis, and primary immunodeficiency diseases.
Along with many other patient advocates in the MAPRx Coalition, we strongly opposed a recent MedPAC effort to place Medicare cost savings ahead of the best interests of Medicare patients. Specifically, we urged MedPAC to reject proposals to make changes to true out-of-pocket costs (TrOOP); increase copays for low-income subsidy (LIS) beneficiaries; and eliminate any of the protected classes.
RetireSafe joined with numerous patient groups to comment on the CMS Advance Notice and Draft Call Letter issued on February 19, 2016. The comments focused on better patient access to Medicare Part D Prescription Drugs and related specifically to: Specialty Tier Thresholds, Tier Labeling and Composition, Generic Tier $0 Copay Plans, Formulary Oversight, Drug Utilization Review Controls, Coverage Determination Timelines, and Access to Preferred Cost-sharing Pharmacies.
RetireSafe has continued to work with a large number of patient groups (on several occasions) to strongly oppose the Centers for Medicare Services (CMS) Centers for Medicare and Medicaid Innovation (CMMI) March 8, 2016 proposed rule that would implement substantial changes to the Medicare Part B payment program. As we have stated in several joint letters to Members of Congress and to CMS, we believe the proposed changes which have been proposed as a demonstration project would impact some 75 percent of Medicare population and could limit access to the full range of available treatments under Part B to treat serious illnesses and medical treatments such as cancer, multiple sclerosis, primary immune deficiency, macular degeneration and schizophrenia. Unfortunately, the proposed program will be, in fact, mandatory for many physicians and their patients, and will cause patients to switch from the most appropriate treatment to less effective therapies or to forego treatment altogether because of transportation hurdles created by the new rule. RetireSafe also objects to the lack of sufficient stakeholder input from the beginning of this rule-making process, which has now created one-size-fits-all government payment policies that ignore patient differences and completely undermines the goal of patient-centered Medicare.
Cited source text, amounts, lobbyists, and targets
RetireSafe worked as a leader, along with other patient advocate groups, to oppose any new cuts to the Medicare Advantage payment rates for 2016.
RetireSafe worked with the Medicare Access for Patients Rx Coalition (MAPRx) to raise concerns regarding the Advance Notice of Methodological Changes for Calendar Year 2016 for Medicare Advantage Capitation Rates, Part C and Part D Payment Policies and 2016 Call Letter to express concerns related to: the Exceptions and Appeals Process, Star Ratings and the Dual-Eligibles, Formulary Oversight, Drug Utilization Review Controls, Tier Labeling and Composition, Specialty Tiers, and the Use of Multiple Tiers with Coinsurance Cost-Sharing Rates.
RetireSafe joined with the Medicare Rights Center and other patient advocates to urge numerous changes to the Medicare Part D Program to make the Exceptions and Appeals Processes More Accessible for Beneficiaries.
RetireSafe joined with the Healthcare Leadership Council and others to support the Protecting Seniors Access to Medicare Act, (H.R. 1190 and S. 141) to repeal the Independent Payment Advisory Board (IPAB), authorized under the Patient Protection and Affordable Care Act.
Support H.R. 2624 and S. 1488, the Part D Beneficiary Appeals Fairness Act.
Support the passage of H.R. 160 to repeal the 2.3% Medical Device Tax.
Support the passage of H.R. 1190 to repeal the Independent Payment Advisory Board (IPAB).
Joined with the MAPRx coalition to urge Congress to build on the success of Medicare Part D to ensure robust formularies, coverage for the six-protected classes, strong oversight, and transparency for consumers, as well as add improvements to the process for notice of non-coverage, appeals and exceptions.
Also, urged Part D remedies to correct gaps in coverage, onerous cost-shifting created by specialty tiers, and restrictive utilization management tools that severely reduce patient benefits.
Support "340B" Medicaid program reform to end widespread abuse of the drug discount program that ultimately harms patients.
Joined with other patient advocate groups to comment on proposed rule: CMS-2390-P-Medicaid and Childrens Health Insurance Programs (CHIP); Medicaid Managed Care, CHIP Delivered in Managed Care, Medicaid and CHIP Comprehensive Quality Strategies, and Revisions Related to Third Party Liability. We supported the proposed rules intent to strengthen program integrity safeguards, and ensure beneficiary protections in areas of provider networks, coverage standards, and the treatment of appeals. We agree with the other groups that a modernized Medicaid managed care regulatory structure is essential to facilitate necessary system reform initiatives, and advance the delivery of health care for millions of people, and we supported rule changes to achieve those goals.
RetireSafe joined with other patient advocates to comment on proposed rule: CMS-1631-P-Medicare Program; Revisions to Payment Policies under the Physician Fee Schedule and Other Revisions to Part B for CY2016. In commenting we supported various measures for improving accuracy for primary care and care management services; providing appropriate advanced care planning services; providing better Medicare Tele-health services; providing better Chronic Care Management services for Rural Health Clinics and Qualified Health Centers; providing a useful Physicians Compare Website with data in proper context; and providing physician payment, efficiency, and quality improvements linked to a physician quality reporting system.
RetireSafe joined with numerous patient groups to oppose a new CMS plan to cut the payment rate (from Average Sales Price plus 6%) for Medicare Part B Drugs administered by physicians in large parts of the U.S. because this Center for Medicare & Medicaid initiative focuses on costs rather than patients needs and health care quality. This new Part B Drug Plan will adversely impact Medicare patients with complex conditions such as cancer, macular degeneration, hypertension, rheumatoid arthritis, and primary immunodeficiency diseases.
Along with many other patient advocates in the MAPRx Coalition, we strongly opposed a recent MedPAC effort to place Medicare cost savings ahead of the best interests of Medicare patients. Specifically, we urged MedPAC to reject proposals to make changes to true out-of-pocket costs (TrOOP); increase copays for low-income subsidy (LIS) beneficiaries; and eliminate any of the protected classes.
RetireSafe joined with numerous patient groups to comment on the CMS Advance Notice and Draft Call Letter issued on February 19, 2016. The comments focused on better patient access to Medicare Part D Prescription Drugs and related specifically to: Specialty Tier Thresholds, Tier Labeling and Composition, Generic Tier $0 Copay Plans, Formulary Oversight, Drug Utilization Review Controls, Coverage Determination Timelines, and Access to Preferred Cost-sharing Pharmacies.
Cited source text, amounts, lobbyists, and targets
Issues relating to implementation of legislative or regulatory changes to Medicare and Medicaid, including Medicare Part B drug reimbursement. Issues before CMS relating to Medicare payment for preventive screening, coordinated patient care, care planning; H.R.1220 & S.624, Removing Barriers to Colorectal Cancer Screening Act; and H.R.1190, Protecting Seniors' Access to Medicare Act and issues relating to CMS-issued regulations pertaining to Medicare Part B reimbursement, regulations relating to the Medicare Access and CHIP Reauthorization Act of 2015.
Client expense: $1,640,000 · Firm income: Not reported
The resolution provides for consideration of H.R. 160 and H.R. 1190. Each bill is closed under the rule, and shall be debatable for 1 hour. The resolution also provides for one motion to recommit with or without instructions for both bills.
June 18, 2015
Considered under the provisions of rule H. Res. 319. (consideration: CR H4528-4535; text of measure as reported in House: CR H4528)
June 17, 2015
Rule H. Res. 319 passed House.
June 16, 2015
Rules Committee Resolution H. Res. 319 Reported to House. The resolution provides for consideration of H.R. 160 and H.R. 1190. Each bill is closed under the rule, and shall be debatable for 1 hour. The resolution also provides for one motion to recommit with or without instructions for both bills.
June 12, 2015
Placed on the Union Calendar, Calendar No. 108.
June 12, 2015
Committee on Rules discharged.
June 12, 2015
Committee on Rules discharged.
June 12, 2015
Committee on Energy and Commerce discharged.
June 12, 2015
Committee on Energy and Commerce discharged.
June 12, 2015
Reported by the Committee on Ways and Means. H. Rept. 114-150, Part I.
Congress.gov source codes: 5000, H12200
June 2, 2015
Ordered to be Reported by the Yeas and Nays: 31 - 8.
June 2, 2015
Committee Consideration and Mark-up Session Held.
March 27, 2015
Referred to the Subcommittee on Health.
March 6, 2015
Referred to the Subcommittee on Health.
March 2, 2015
Referred to the Committee on Ways and Means, and in addition to the Committees on Energy and Commerce, and Rules, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), White House Office
Cited source text, amounts, lobbyists, and targets
Issues surrounding the enactment or repeal of the Affordable Care Act, including IPAB and ACOs. Medicare reimbursement reform for providers including the Medicare Access and CHIP Reauthorization Act (MACRA). Medicare Part B Drug Reimbursement. FDA issues and Issues surrounding the tissue bank industry. HR 1190 and S. 141: Protecting Seniors' Access to Medicare Act (IPAB repeal). HR 2, the Medicare Patient Access and Quality Improvement Act (SGR reform). Implementation of The Breast Cancer Patient Education Act. HR 1221/S 626, the Helping Ensure Life- and Limb-Saving Access to Podiatric Physicians (HELLPP) Act. Training Tomorrows Doctors Today Act, and The Resident Physician Shortage Reduction Act. The Palliative Care and Hospice Education and Training Act. Issues and regulations governing the use and deployment of speech generating devices (SGDs) S.984 The Steve Gleason Act. Antibiotic Development to Advance Patient Treatment (ADAPT) Act. The 21st Century Cures Act, HR 6 and the Senate Innovations legislation. Ensuring Access to General Surgery Act - HR 4959. Draft legislation to reform the FDA's regulation of cosmetics. Provisions relating to combat surgical training and standards in the National Defense Authorization Act.
Client expense: Not reported · Firm income: $20,000
Cited source text, amounts, lobbyists, and targets
H.R.290-Creating Access to Rehabilitation for Every Senior (CARES) Act of 2015
H.R.1190-Protecting Seniors Access to Medicare Act of 2015
H.R.1571-Improving Access to Medicare Coverage Act of 2015
H.R.2298-Medicare Patient Safety and Drug Abuse Prevention Act
H.R.2646-Helping Families in Mental Health Crisis Act of 2015
H.R.2799-Furthering Access to Stroke Telemedicine (FAST) Act
H.R.2948-Medicare Telehealth Parity Act of 2015
H.R.3081-TELEmedicine for MEDicare (TELE-MED) Act of 2015
H.R.3288-Strengthening DSH and Medicare Through Subsidy Recapture and Payment Reform Act of 2015
H.R.3291-Medicare Crosswalk Hospital Code Development Act of 2015
H.R.3292-Medicare IME Pool Act of 2015
H.R.3762-Restoring Americans' Healthcare Freedom Reconciliation Act of 2015
H.R.3770-End Surprise Billing Act of 2015
H.R.4059-Medicare Choices Empowerment and Protection Act
H.R.4435-Comprehensive Behavioral Health Reform and Recovery Act of 2016
H.R.5273-Helping Hospitals Improve Patient Care
H.R.5284-World's Greatest Healthcare Plan Act of 2016
H.R.5547-Health Care Price Transparency Promotion Act of 2016
S.141-Protecting Seniors Access to Medicare Act of 2015
S.599-Improving Access to Emergency Psychiatric Care Act
S.843-Improving Access to Medicare Coverage Act of 2015
S.1465-Furthering Access to Stroke Telemedicine (FAST) Act
S.1549-Care Planning Act of 2015
S.1648-Rural Emergency Acute Care Hospital (REACH) Act
S.1778-TELEmedicine for MEDicare (TELE-MED) Act of 2015
S.1913-Stopping Medication Abuse and Protecting Seniors Act of 2015
S.2297-Medicare Choices Empowerment and Protection Act
S.2525-Expand Excellence in Mental Health Act
S.2680-Mental Health Reform Act of 2016
S.2985-World's Greatest Healthcare Plan Act of 2016
P.L.114-10-Medicare Access and CHIP Reauthorization Act of 2015
Client expense: $462,139 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
H.R.6-21st Century Cures Act
H.R.33-Protecting Volunteer Firefighters and Emergency Responders Act
H.R.34-21st Century Cures Act
H.R.290-Creating Access to Rehabilitation for Every Senior (CARES) Act of 2015
H.R.293-To amend title XI of the Social Security Act to exempt from manufacturer transparency reporting certain transfers used for educational purposes, and for other purposes.
H.R.398-Trafficking Awareness Training for Health Care Act
H.R.639-Improving Regulatory Transparency for New Medical Therapies Act
H.R.647-Access to Life-Saving Trauma Care for All Americans Act
H.R.648-Trauma Systems and Regionalization of Emergency Care Reauthorization Act
H.R.836-Health Care Safety Net Enhancement Act
H.R.953-Comprehensive Addiction and Recovery Act of 2015
H.R.1190-Protecting Seniors Access to Medicare Act of 2015
H.R.1571-Improving Access to Medicare Coverage Act of 2015
H.R.1641-Jason Simcakoski Memorial Opioid Safety Act
H.R.1725-National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015
H.R.1818-Veteran Emergency Medical Technician Support Act of 2015
H.R.1821-Opioid Overdose Reduction Act of 2015
H.R.1854-Comprehensive Justice and Mental Health Act of 2015
H.R.1877-Mental Health First Aid Act of 2015
H.R.2050-Middle Class Health Benefits Tax Repeal Act of 2015
H.R.2298-Medicare Patient Safety and Drug Abuse Prevention Act
H.R.2366-Field EMS Modernization and Innovation Act
H.R.2463-Dispose Responsibly of your Pills (DROP) Act of 2015
H.R.2536-Recovery Enhancement for Addiction Treatment (TREAT) Act
H.R.2603-Saving Lives, Saving Costs Act
H.R.2646-Helping Families in Mental Health Crisis Act of 2015
H.R.2799-Furthering Access to Stroke Telemedicine (FAST) Act
H.R.2805-Heroin and Prescription Opioid Abuse Prevention, Education, and Enforcement Act of 2015
H.R.2850-Stop Overdose Stat Act of 2015
H.R.2872-Opioid Addiction Treatment Modernization Act
H.R.2948-Medicare Telehealth Parity Act of 2015
H.R.3014-Medical Controlled Substances Transportation Act of 2015
H.R.3081-TELEmedicine for MEDicare (TELE-MED) Act of 2015
H.R.3250-DXM Abuse Prevention Act of 2015
H.R.3299-Strengthening Public Health Emergency Response Act
H.R.3537-Synthetic Drug Control Act of 2015
H.R.3677-Opioid Abuse Prevention and Treatment Act of 2015
H.R.3680-Co-Prescribing to Reduce Overdose Act of 2015
H.R.3681-Improving Access to Emergency Psychiatric Care Act
H.R.3682-Reducing Employer Burdens, Unleashing Innovation, and Labor Development Act of 2015
H.R.3691-Improving Treatment for Pregnant and Postpartum Women Act of 2015
H.R.3762-Restoring Americans' Healthcare Freedom Reconciliation Act of 2015
H.R.3770-End Surprise Billing Act of 2015
H.R.3865-Cradle Act
H.R.4059-Medicare Choices Empowerment and Protection Act
H.R.4063-Promoting Responsible Opioid Management and Incorporating Scientific Expertise Act
H.R.4150-Department of Veterans Affairs Emergency Medical Staffing Recruitment and Retention Act
H.R.4365-Protecting Patient Access to Emergency Medications Act of 2016
H.R.4435-Comprehensive Behavioral Health Reform and Recovery Act of 2016
H.R.4447-Opioid and Heroin Epidemic Emergency Supplemental Appropriations Act
H.R.4499-Promoting Responsible Opioid Prescribing Act of 2016
H.R.4599-Reducing Unused Medications Act of 2016
H.R.4641-To provide for the establishment of an inter-agency task force to review, modify, and update best practices for pain management and prescribing pain medication, and for other purposes.
H.R.4697-Prevevent Drug Addiction Act of 2016
H.R.4771-Help Efficient, Accessible, Low-cost, Timely Healthcare (HEALTH) Act of 2016
H.R.4732-Advancing Medical Resident Training in Community Hospitals Act of 2016
H.R.5243-Zika Response Appropriations Act
H.R.5273-Helping Hospitals Improve Patient Care
H.R.5284-World's Greatest Healthcare Plan Act of 2016
H.R.5547-Health Care Price Transparency Promotion Act of 2016
H.Res.877-Encouraging each State to enact legislation that increases the likelihood of survival after sudden cardiac arrest in our Nation's schools.
S.141-Protecting Seniors Access to Medicare Act of 2015
S.425-Homeless Veterans' Reintegration Programs Reauthorization Act of 2015
S.453-Veteran Emergency Medical Technician Support Act of 2015
S.480-National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015
S.524-Comprehensive Addiction and Recovery Act of 2015
S.599-Improving Access to Emergency Psychiatric Care Act
S.636-Increasing the Safety of Prescription Drug Use Act of 2015
S.707-Opioid Overdose Reduction Act of 2015
S.711-Mental Health First Act of 2015
S.763-Trauma Systems and Regionalization of Emergency Care Reauthorization Act
S.884-Health Care Safety Net Enhancement Act
S.843-Improving Access to Medicare Coverage Act of 2015
S.954-FDA Accountability for Public Safety Act
S.993-Comprehensive Justice and Mental Health Act of 2015
S.1134-Heroin and Prescription Opioid Abuse Prevention, Education, and Enforcement Act of 2015
S.1392-Safer Prescribing of Controlled Substances Act
S.1410-Treatment and Recovery Investment Act
S.1431-Prescription Drug Abuse Prevention and Treatment Act of 2015
S.1446-SOAR to Health and Wellness Act of 2015
S.1450-Department of Veterans Affairs Emergency Medical Staffing Recruitment and Retention Act
S.1452-Veterans Emergency Health Safety Net Expansion Act of 2015
S.1455-Recovery Enhancement for Addiction Treatment Act
S.1465-Furthering Access to Stroke Telemedicine (FAST) Act
S.1475-Saving Lives, Saving Costs Act
S.1549-Care Planning Act of 2015
S.1648-Rural Emergency Acute Care Hospital (REACH) Act
S.1654-Overdose Prevention Act
S.1693-To amend title 38, United States Code, to expand eligibility for reimbursement for emergency medical treatment to certain veterans that were unable to receive care from the Department of Veterans Affairs in the 24-month period preceding the furnishing of such emergency treatment, and for other purposes.
S.1778-TELEmedicine for MEDicare (TELE-MED) Act of 2015
S.1893-Mental Health Awareness and Improvement Act of 2015
S.1913-Stopping Medication Abuse and Protecting Seniors Act of 2015
S.1945-Mental Health Reform Act of 2015
S.2002-Mental Health and Safe Communities Act of 2015
S.2045-Middle Class Health Benefits Tax Repeal Act of 2015
S.2256-Co-Prescribing Saves Lives Act of 2015
S.2297-Medicare Choices Empowerment and Protection Act
S.2525-Expand Excellence in Mental Health Act
S.2562-Heroin and Prescription Drug Abuse Prevention and Reduction Act
S.2567-Preventing Overprescribing for Pain Act of 2016
S.2578-Reducing Unused Medications Act of 2016
S.2597-Medicare Mental Health Access Act
S.2671-Advancing Medical Resident Training in Community Hospitals Act of 2016
S.2680-Mental Health Reform Act of 2016
S.2687-Plan of Safe Care Improvement Act
S.2932-Protecting Patient Access to Emergency Medications Act of 2016
S.2985-World's Greatest Healthcare Plan Act of 2016
S. 3407, Military Injury Surgical Systems Integrated Operationally Nationwide to Achieve ZERO Preventable Deaths (MISSION ZERO) Act
P.L.114-10-Medicare Access and CHIP Reauthorization Act of 2015
P.L.114-324-Justice for All Reauthorization Act
Client expense: $462,139 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
Issues regarding reimbursement and Medicare program issues regarding long term care and post acute care vendors, suppliers, and providers including cuts to portable x-ray providers and including the following: HR 6 21st Century Cures Initiative, Medicare Tele Health Parity Act of 2015 H.R. 2948, improving information technology interoperability, electronic prescribing, S. 1349/H.R. 876, Improving Access to Medicare Coverage Act of 2015 S.843/H.R.1571, Medicare Post-Acute Care Value-Based Purchasing H.R. 3298,Protecting Seniors Access to Medicare Act of 2015 H.R. 1190, Medical Device Tax Repeal Bill H.R. 160, Audit and Appeals Fairness, Integrity, and Reforms in Medicare (AFIRM) Act of 2015, Consolidated Appropriations Act.
Client expense: $20,000 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
Lobbying Issues Description:
Budget and appropriations for disease and injury prevention, including obesity and
related diseases; pandemic influenza and emerging infectious diseases; physical
activity; public health bioterrorism preparedness; food safety, environmental health;
paid sick days; womens and childrens health; community-based public health
interventions and prescription drug abuse.
Specific Legislation:
1. Implementation of the Patient Protection and Affordable Care Act (Public Law
111-148)
2. Implementation of the FDA Food Safety Modernization Act (Public Law 111-
353)
3. Implementation of Pandemic and All-Hazards Preparedness Reauthorization
Act (Public Law 113-5)
4. Implementation of Healthy, Hunger-Free Kids Act of 2010 (Public Law 111-
296)
5. Implementation of the Budget Control Act of 2011 (Public Law 112-25)
6. Implementation of the Pandemic and All-Hazards Preparedness
Reauthorization Act of 2013 (Public Law 113-5)
7. Implementation of the Drug Quality and Security Act of 2013 (Public Law
113-54)
8. Implementation of Animal Drug and Animal Generic Drug User Fee Act
(Public Law 113-14)
9. Implementation of Child Care and Development Block Grant Act of 2014
(Public Law 113-186)
10. Promoting Health as Youth Skills in Classrooms and Life Act (S. 418)
11. National Diabetes Clinical Care Commission Act (H.R. 1192/S. 586)
12. Energy Consumers Relief Act (S. 156)
13. FIT Kids Act (S. 1075/H.R. 2013)
14. Climate Change Health Protection and Promotion Act (H.R. 1275)
15. Treat and Reduce Obesity Act (S. 1509/H.R. 2404)
16. A bill to amend the Congressional Budget Act of 1974 respecting the scoring
of preventive health savings (H.R. 3660)
17. Developing a Reliable and Innovation Vision for the Economy (DRIVE) Act
(S. 1647)
18. Summer Meals Act of 2014 (S. 613/H.R. 1728)
19. Long-Term SCORE Act (H.R. 282/S. 2260)
20. American Cures Act (S. 289)
21. School Food Modernization Act (S. 540)
22. Protecting Children from Electronic Cigarette Advertising Act of 2014 (S.
430/H.R. 478)
23. Bicycle and Pedestrian Infrastructure Improvement Act of 2015 (H.R. 199)
24. Waters of the United States Regulatory Overreach Protection Act of 2014
(H.R. 594)
25. Promise for Antibiotics and Therapeutics for Health Act (PATH Act, S. 185)
26. Helping Effective Antibiotics Last (HEAL) Act (H.R. 931)
27. Safe Food Act of 2015 (H.R. 609/S. 287)
28. 21st Century Cures Act (H.R. 6/H.R 34)
29. Preservation of Antibiotics for Medical Treatment Act (H.R. 1552)
30. Preventing Antibiotic Resistance Act (S. 621)
31. Healthy Families Act (H.R. 932/S. 497)
32. Developing an Innovative Strategy for Antimicrobial Resistant
Microorganisms (DISARM) Act (H.R. 512)
33. Antibiotic Development to Advance Patient Treatment Act (H.R. 2629)
34. Recognizing the importance of vaccinations and immunizations in the United
States (H.Res. 117)
35. Good Samaritan Health Professionals Act (H.R. 865/S. 3101)
36. Head Start on Vaccinations Act (H.R. 933/S. 486)
37. Opioid Overdose Reduction Act (S. 707/H.R. 1821)
38. Comprehensive Addiction and Recovery Act (S. 524/H.R. 953)
39. CHIP Extension and Improvement Act of 2015 (S. 522/H.R. 919)
40. Secret Science Reform Act of 2015 (S. 544/H.R. 1030)
41. EPA Science Advisory Board Reform Act of 2015 (S. 543/H.R. 1029)
42. Medicare Access and CHIP Reauthorization Act of 2015 (H.R. 2)
43. Student Success Act (H.R. 5)
44. Every Child Achieves Act (S. 1177)
45. Sugar-Sweetened Beverages Tax (SWEET) Act (H.R. 1687)
46. Transportation Alternatives Program Improvement Act (S. 705)
47. Jason Simcakoski Memorial Opioid Safety Act (S. 1641/H.R. 4063)
48. Recovery Enhancement for Treatment (TREAT) Act (S. 1455/H.R. 2536)
49. FDA Deeming Authority Clarification Act (H.R. 2058)
50. Pathogen Reduction and Testing Reform Act (H.R. 2303)
51. Medicare Diabetes Prevention Act (S. 1131/H.R. 2102)
52. Ratepayer Protection Act (H.R. 2042)
53. Affordable Reliable Electricity Now Act (S. 1324)
54. Protecting Seniors Access to Medicare Act (H.R. 1190/S. 141)
55. Family Asthma Act (S. 1064)
56. School Asthma Management Plan Act (S. 1065)
57. Healthy Relationships Act (H.R. 453/S. 923)
58. Healthy School Meals Flexibility Act (S. 1146/H.R. 2508)
59. Reducing Federal Mandates on School Lunch Act (H.R. 1504)
60. Safe Streets Act (H.R. 2071)
61. Healthy Kids Outdoors (S. 1078/H.R. 2014)
62. Highway and Transportation Funding Act (H.R. 2353)
63. Federal Water Quality Protection Act (S. 1140)
64. Friendly Airports for Mothers Act (H.R. 2530)
65. Overdose Prevention Act (S. 2092/H.R. 4288)
66. Stop Overdose Stat Act (H.R. 2850)
67. Stop Child Summer Hunger Act (S. 1539/H.R. 2715)
68. Promoting Physical Activity for Americans Act (S. 1793/H.R. 1499)
69. Defund Planned Parenthood Act of 2015 (H.R. 3134)
70. Continuing Appropriations Act, 2016 (H.R. 719)
71. Strengthening Public Health Emergency Response Act (H.R. 3299)
72. Consolidated Appropriations Act, 2016 (Public Law 114-113)
73. Restoring Americans Healthcare Freedom Reconciliation Act of 2015 (H.R.
3762/Senate Amendment)
74. A joint resolution providing for congressional disapproval under chapter 8 of
title 5, United States Code, of the rule submitted by the Corps of Engineers and
the Environmental Protection Agency relating to the definition of "waters of
the United States" under the Federal Water Pollution Control Act (S.J. Res 22)
75. A joint resolution providing for congressional disapproval under chapter 8 of
title 5, United States Code, of a rule submitted by the Environmental
Protection Agency relating to "Standards of Performance for Greenhouse Gas
Emissions from New, Modified, and Reconstructed Stationary Sources:
Electric Utility Generating Units" (S.J.Res. 23)
76. On the Joint Resolution: S.J.Res. 24; A joint resolution providing for
congressional disapproval under chapter 8 of title 5, United States Code, of a
rule submitted by the Environmental Protection Agency relating to "Carbon
Pollution Emission Guidelines for Existing Stationary Sources: Electric Utility
Generating Units" (S.J.Res 24)
77. Common Sense Nutrition Disclosure Act (H.R. 2017/S. 2217)
78. Food Labeling Modernization Act (H.R. 4061/S. 2301)
79. Fixing Americas Surface Transportation Act (Public Law 114-93)
80. Every Student Succeeds Act (Public Law 114-95)
81. Puerto Rico Assistance Act, 2015 (S. 2381)
82. Full-Service Community Schools Act, 2015 (S. 1787)
83. FY2017 Commerce, Justice, State Appropriations Act (S. 2837/H.R. 5393)
84. FY2017 Financial Services and General Government Appropriations Act (S.
3067/H.R. 5485)
85. Energy Policy Modernization Act of 2015 (S. 2012)
86. Hallways to Health Act (S. 2590/H.R. 4621)
87. GET THE LEAD OUT Act of 2016 (S. 2588)
88. CLEAR Act (S. 2587)
89. TEST KIDS Act (S. 2586)
90. FUND Water Act (S. 2583)
91. NURSE Act (S. 2572)
92. A joint resolution providing for congressional disapproval under chapter 8 of
title 5, United States Code, of the rule submitted by the Corps of Engineers and
the Environmental Protection Agency relating to the definition of "waters of
the United States" under the Federal Water Pollution Control Act. (S.J.Res.22)
93. The Ozone Standards Implementation Act of 2016 (H.R. 4775)
94. Ozone National Ambient Air Quality Standard Deadline Harmonization Act of
2015 (H.R. 4000)
95. To repeal the Prevention and Public Health Fund (H.R. 1085)
96. Common Sense Savings Act of 2016 (H.R. 4725)
97. Establishing the congressional budget for the United States Government for
fiscal year 2017 and setting forth the appropriate budgetary levels for fiscal
years 2018 through 2026 (H.Con.Res. 125)
98. Improving Child Nutrition Integrity and Access Act of 2016 (S. 3136)
99. Promoting Biomedical Research and Public Health for Patients Act (S. 2742)
100. Preventing Superbugs and Protecting Patients Act (S. 2503)
101. The Medical Countermeasures Innovation Act (S. 2055)
102. FY2016 Labor, Health and Human Services, and Education Appropriations
Act (S. 1695/H.R. 3020)
103. FY2016 Agriculture, Rural Development, Food and Drug Administration, and
Related Agencies Appropriations Act (S. 1800/H.R. 3049/S. 2129)
104. FY 2016 Financial Services and General Government Appropriations bill, in
support of an appropriation for the National Alliance for Model State Drug
Laws (H.R. 2995/S. 1910/S. 2132)
105. FY2016 Congressional Budget Resolution (S.Con.Res. 11/H.Con.Res 27)
106. FY2016 Homeland Security Appropriations Act (S. 1619/H.R. 3128/S.2131)
107. FY2017 Military Construction-VA Appropriations and Zika Supplemental
(H.R. 2577)
108. Public Health Emergency Preparedness Act (H.R. 4525)
109. PREPARE Act (H.R. 3583)
110. Zika Response Appropriations Act (H.R. 5243)
111. Making Supplemental Appropriations for fiscal year 2016 to respond to Zika
virus (H.R. 5044)
112. A bill to provide emergency supplemental appropriations to address the Zika
crisis (S. 2843)
113. FY 2017 Departments of Labor, Health and Human Services, and Education
and Related Agencies Appropriations Act (S. 3040)
114. FY 2017 Agriculture, Rural Development, Food and Drug Administration, and
Related Agencies Appropriations Act (S. 2956/H.R. 5054)
115. Health Equity and Accountability Act of 2016 (H.R. 5475)
116. SMASH Act (S. 3039)
117. Improving Child Nutrition and Education Act (H.R. 5003)
118. Continuing Appropriations and Military Construction, Veterans Affairs, and
Related Agencies Appropriations Act, 2017, and Zika Response and
Preparedness Act (H.R. 5325)
119. Interior, Environment and Related Agencies Appropriations Bill, 2017 (S.
3068/H.R. 5538)
120. Ozone Standards Implementation Act (S. 2882)
121. National Defense Authorization Act for Fiscal Year 2017 (S. 2943)
122. Environmental Health Workforce Act of 2016 (H.R. 5543)
123. Water Resources Development Act (H.R. 5303/S. 2848)
124. Further Continuing and Security Assistance Act (Public Law 114-254)
Client expense: $40,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Education, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), Federal Emergency Management Agency (FEMA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Housing & Urban Development, Dept of (HUD), Office of Management & Budget (OMB), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA), Transportation, Dept of (DOT)
Cited source text, amounts, lobbyists, and targets
H.R. 2646 - Helping Families in Mental Health Crisis Act of 2015
H.R. 2 - Medicare Access and CHIP Reauthorization Act of 2015
H.R. 6 - 21st Century Cures Act
S. 711 - Mental Health First Act of 2015
S. 599 - Improving Access to Emergency Psychiatric Care Act
S. 149 - Medical Device Access and Innovation Protection Act
H.R. 160 - Protect Medical Innovation Act of 2015
H.R. 1190 - Protecting Seniors' Access to Medicare Act of 2015
S. 141 - Protecting Seniors Access to Medicare Act of 2015
H.R.3762 - Restoring Americans' Healthcare Freedom Reconciliation Act of 2015
S. 1945 - Mental Health Reform Act of 2015
S. 2680 - Mental Health Reform Act of 2016
S. 524 - Comprehensive Addiction and Recovery Act (CARA)
Client expense: Not reported · Firm income: $50,000
Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Executive Office of the President (EOP), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), SENATE
Cited source text, amounts, lobbyists, and targets
H.R. 2646 - Helping Families in Mental Health Crisis Act of 2015
H.R. 2 - Medicare Access and CHIP Reauthorization Act of 2015
H.R. 6 - 21st Century Cures Act
S. 711 - Mental Health First Act of 2015
S. 599 - Improving Access to Emergency Psychiatric Care Act
S. 149 - Medical Device Access and Innovation Protection Act
H.R. 160 - Protect Medical Innovation Act of 2015
H.R. 1190 - Protecting Seniors' Access to Medicare Act of 2015
S. 141 - Protecting Seniors Access to Medicare Act of 2015
H.R.3762 - Restoring Americans' Healthcare Freedom Reconciliation Act of 2015
S. 1945 - Mental Health Reform Act of 2015
S. 2680 - Mental Health Reform Act of 2016
S. 524 - Comprehensive Addiction and Recovery Act (CARA)
Client expense: Not reported · Firm income: $50,000
Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Executive Office of the President (EOP), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), SENATE
Cited source text, amounts, lobbyists, and targets
H.R. 2 - Medicare Access and CHIP Reauthorization Act of 2015
H.R. 6 - 21st Century Cures Act
S. 995 - Bipartisan Congressional Trade Priorities and Accountability Act of 2015
H.R. 2581 - Preservation of Access for Seniors in Medicare Advantage Act of 2015
S. 149 - Medical Device Access and Innovation Protection Act
H.R. 160 - Protect Medical Innovation Act of 2015
H.R. 2156 - Medicare Audit Improvement Act of 2015
S. 1268 - Trade Adjustment Assistance Reauthorization Act of 2015
H.R. 1295 - Trade Preferences Extension Act of 2015
H.R. 1190 - Protecting Seniors' Access to Medicare Act of 2015
S. 141 - Protecting Seniors Access to Medicare Act of 2015
H.R.3762 - Restoring Americans' Healthcare Freedom Reconciliation Act of 2015
S.754 - Cybersecurity Information Sharing Act of 2015
Client expense: Not reported · Firm income: $40,000
Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Executive Office of the President (EOP), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), SENATE
Cited source text, amounts, lobbyists, and targets
H.R. 2 - Medicare Access and CHIP Reauthorization Act of 2015
H.R. 6 - 21st Century Cures Act
S. 995 - Bipartisan Congressional Trade Priorities and Accountability Act of 2015
H.R. 2581 - Preservation of Access for Seniors in Medicare Advantage Act of 2015
S. 149 - Medical Device Access and Innovation Protection Act
H.R. 160 - Protect Medical Innovation Act of 2015
H.R. 2156 - Medicare Audit Improvement Act of 2015
S. 1268 - Trade Adjustment Assistance Reauthorization Act of 2015
H.R. 1295 - Trade Preferences Extension Act of 2015
H.R. 1190 - Protecting Seniors' Access to Medicare Act of 2015
S. 141 - Protecting Seniors Access to Medicare Act of 2015
H.R.3762 - Restoring Americans' Healthcare Freedom Reconciliation Act of 2015
S.754 - Cybersecurity Information Sharing Act of 2015
Client expense: Not reported · Firm income: $40,000
Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Executive Office of the President (EOP), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), SENATE
Cited source text, amounts, lobbyists, and targets
Medicare Program; Part B Drug Payment Model, Proposed rule, CMS-1670-P (March 11, 2016) - Provisions related to the Medicare Part B Drug Payment Model
Medicaid Program: Covered Outpatient Drugs (CMS-2345-FC) - Provisions related to line extension drug definition, effective date and other issues
Medicare Program; Revisions to Payment Policies Under the Physician Fee Schedule (CMS-1654-P) - Expansion of Medicare Diabetes Prevention Program Model
S. 31: Medicare Prescription Drug Price Negotiation Act of 2015 - Provisions related to Secretary negotiation authority in Part D program
S. 141: Protecting Seniors' Access to Medicare Act of 2015 - Provisions related to Independent Payment Advisory Board (IPAB) repeal
S. 648: Medicare Formulary Improvement Act of 2015 - Provisions related to codification of six protected classes in Part D program
S. 1083: Medicare Drug Savings Act of 2015 - Provisions related to drug rebates in Medicare Part D
S. 2023: Prescription Drug Affordability Act of 2015 - Provisions related to Secretary negotiation authority in Part D program, Medicare and Medicaid rebates, resolution of government enforcement actions, and reporting of certain drug manufacturer expenditures
S. 2981: A bill to amend title XIX of the Social Security Act to add standards for drug compendia for physician use for purposes of Medicaid payment for certain drugs, and for other purposes
H.R. 22: FAST Act - Medicare related offsets to the biopharmaceutical industry
H.R. 1190: Protecting Seniors Access to Medicare Act of 2015 - Provisions related to IPAB repeal
H.R. 2005: Medicare Drug Savings Act of 2015 - Provisions related to changes to Part D rebates
H.R. 3513: Prescription Drug Affordability Act of 2015 - Provisions related to Secretary negotiation authority in Part D program, Medicare and Medicaid rebates, resolution of government enforcement actions, and reporting of certain drug manufacturer expenditures
H.R. 5122: To prohibit further action on the proposed rule regarding testing of Medicare part B prescription drug models - Suspending the Part B Drug Payment Model
Proposed Medicare hospital outpatient prospective payment system (OPPS) rule for 2016 (CMS-1656-P)
Department of Health and Human Services (HHS) delivery system reform issues and regulatory barriers to innovation
Medicare Part B Average Sales Price (ASP) policy issues
Medicare Part D rebates policy issues
Drug cost and pricing policy issues
Transparency policy issues
Alternative payment models policy issues
Value-based arrangements policy issues
Coding and reimbursement policy issues including for biologics
Prescription drug abuse policy issues
Center for Medicare and Medicaid Innovation (CMMI) transparency and other policy issues
MedPAC June Report - Part B and D policy issues
Medicaid rebates/reformulations policy issues
Non-interference policy issues
Client expense: $492,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR)
Cited source text, amounts, lobbyists, and targets
Medicare Program; Part B Drug Payment Model, Proposed rule, CMS-1670-P (March 11, 2016) - Provisions related to the Medicare Part B Drug Payment Model
Medicaid Program: Covered Outpatient Drugs (CMS-2345-FC) - Provisions related to line extension drug definition, effective date and other issues
Medicare Program; Revisions to Payment Policies Under the Physician Fee Schedule (CMS-1654-P) - Expansion of Medicare Diabetes Prevention Program Model
S. 31: Medicare Prescription Drug Price Negotiation Act of 2015 - Provisions related to Secretary negotiation authority in Part D program
S. 141: Protecting Seniors' Access to Medicare Act of 2015 - Provisions related to Independent Payment Advisory Board (IPAB) repeal
S. 648: Medicare Formulary Improvement Act of 2015 - Provisions related to codification of six protected classes in Part D program
S. 1083: Medicare Drug Savings Act of 2015 - Provisions related to drug rebates in Medicare Part D
S. 2023: Prescription Drug Affordability Act of 2015 - Provisions related to Secretary negotiation authority in Part D program, Medicare and Medicaid rebates, resolution of government enforcement actions, and reporting of certain drug manufacturer expenditures
H.R. 22: FAST Act - Medicare related offsets to the biopharmaceutical industry
H.R. 1190: Protecting Seniors Access to Medicare Act of 2015 - Provisions related to IPAB repeal
H.R. 2005: Medicare Drug Savings Act of 2015 - Provisions related to changes to Part D rebates
H.R. 3513: Prescription Drug Affordability Act of 2015 - Provisions related to Secretary negotiation authority in Part D program, Medicare and Medicaid rebates, resolution of government enforcement actions, and reporting of certain drug manufacturer expenditures
H.R. 5122: To prohibit further action on the proposed rule regarding testing of Medicare part B prescription drug models - Suspending the Part B Drug Payment Model
Department of Health and Human Services (HHS) delivery system reform issues and regulatory barriers to innovation
Medicare Part B Average Sales Price (ASP) policy issues
Medicare Part D rebates policy issues
Drug cost and pricing policy issues
Transparency policy issues
Alternative payment models policy issues
Value-based arrangements policy issues
Coding and reimbursement policy issues including for biologics
Prescription drug abuse policy issues
Center for Medicare and Medicaid Innovation (CMMI) transparency and other policy issues
MedPAC June Report - Part B and D policy issues
Medicaid rebates/reformulations policy issues
Non-interference policy issues
Client expense: $4,990,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)
Cited source text, amounts, lobbyists, and targets
Advocate regarding proposed regulations under Medicare Access and CHIP Reauthorization Act of 2015 (P.L. 114-10).
Advocate against CMS proposal regarding collection of data for all 10- and 90- day global surgery services.
Advocate for adequate and accurate network coverage for dermatologic care within Medicare Advantage and health insurance exchange networks (S. 2392 / H.R. 4227, the Medicare Advantage Bill of Rights Act of 2015).
Support legislation to eliminate the Independent Payment Advisory Board (S.141/ H.R. 1190, Protecting Seniors' Access to Medicare Act of 2015).
Lobby Congress on improvements to Health Information Technology implementation.
Lobby Congress on issues related to telemedicine and Medicare reimbursement.
Support legislation to have telemedicine services reimbursable by Medicare (S. 2484/ H.R. 4442, the Creating Opportunities Now for Necessary and Effective Care Technologies for Health Act).
Advocate on use and availability of health care data.
Lobby in support of legislation to provide more flexibility in the Meaningful Use program (H.R. 3309, the Further Flexibility in HIT Reporting and Advancing Interoperability (Flex IT 2) Act).
Advocate for EHR interoperability and enhancements to the federal certification system for health information technology; advocate for provisions to restrict data blocking by Electronic Health Records vendors (S. 2141, Transparent Ratings on Usability & Security to Transform Technology Act of 2015, S.2511, Improving Health Information Technology Act and H.R. 6/H.R. 34, 21st Century Cures Act).
Advocate for improving disease management and care coordination for patients with chronic diseases (H.R. 6/H.R. 34, 21st Century Cures Act).
Support preservation of the In-Offices Ancillary Services Exemption under Stark Law regarding physician self-referral.
Advocate against H.R. 5008, Promoting Integrity in Medicare Act of 2016
Support legislation to provide more flexibility in compliance with the Sunshine Act (S.2978).
Support legislation to have telemedicine services reimbursable by Medicare (S. 2484/H.R. 4442, the Creating Opportunities Now for Necessary and Effective Care Technologies for Health Act).
Support S. 2978, Protecting Continuing Physician Education & Patient Care Act.
Advocate for increased graduate medical education funding.
Client expense: $350,000 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
(1) Issues related to Public Law 111-148 - The Patient Protection and Affordable Care Act (provisions related to Medicaid and Medicare)
(2) Issues related to Public Law 111-152 - Health Care and Education Reconciliation Act of 2010 (provisions related to Medicaid and Medicare)
(3) Issues pertaining to entitlement reform, Medicare Advantage, Part D, Medicaid Dual Eligibles, and Medicare reimbursement and enrollment
(4) Issues related to S.2498 - Medicare Program Linking Uncoordinated Services (PLUS) Act
(5) Issues related to H.R. 2581 - Preservation of Access for Seniors in Medicare Advantage Act
(6) Issues related to H.R. 1190 - Protecting Seniors Access to Medicare Act of 2015
(7) Issues related to H.R. 2505 - Medicare Advantage Coverage Transparency Act of 2015
(8) Issues related to H.R. 2506 - Seniors Health Care Plan Protection Act of 2015
(9 Issues related to H.R. 2507 - Increasing Regulatory Fairness Act of 2015
(10)Issues related to H.R. 2579 - Securing Care for Seniors Act of 2015
(11) Issues related to H.R.3244 - Providing Innovative Care for Complex Cases Demonstration Act of 2015
(12) Issues related to H.R.3288 - Strengthening DSH and Medicare Through Subsidy Recapture and Payment Reform Act of 2015
(13) Issues related to H.R. 4275 - Medicare Advantage Quality Payment Relief Act of 2015
(14) Issues related to H.R.3831 - Securing Fairness in Regulatory Timing Act of 2015
(15) Issues related to H.R.2582 - Seniors' Health Care Plan Protection Act of 2015
(16) Issues related to CMS Advance Notice of Methodological Changes for Calendar Year (CY) 2017 for Medicare Advantage (MA) Capitation Rates, Part C and Part D Payment Policies and 2017 Call Letter
(17) Issues related to H.R.5659, ESRD Choice Act of 2016
Client expense: $620,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), SENATE, Treasury, Dept of
Cited source text, amounts, lobbyists, and targets
- Treat and Reduce Obesity Act (H.R. 2404/S. 1509)
- Issues related to Medicare diabetes screening, generally, Medicare Part D, Special Dabetes Program, obesity, and medical nutrition therapy services
- IPAB, generally, including the Protecting Seniors' Access to Medicare Act (H.R. 1190/S. 141)
- Access to Quality Diabetes Education Act (H.R. 1726)
- CMMI Part B Drug Price Demonstration Program
- Medicare Diabetes Prevention Act (H.R. 2102 and S. 1131)
Client expense: Not reported · Firm income: $50,000
Cited source text, amounts, lobbyists, and targets
H.R. 4499, Promoting Responsible Opioid Prescribing (PROP) Act of 2016, provisions relating to payment and delivery reform
S. 2758, Promoting Responsible Opioid Prescribing (PROP) Act of 2016, provisions relating to payment and delivery reform
S. 3130, Independence at Home Act of 2016, all provisions
H.R. 3220, Medicare Common Access Card Act of 2015, all provisions
S. 3504, Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2016, all provisions
H.R.6333, To amend title XVIII of the Social Security Act with respect to the accreditation of osteopathic residency training programs for purposes of graduate medical education payments under the Medicare program, all provisions
H.R. 976, Patient Access to Higher Quality Health Care Act of 2015, all provisions
H.R. 2, Medicare Access and CHIP Reauthorization Act of 2015, provisions relating to payment and delivery reform
H.R. 1470, SGR Repeal and Medicare Provider Payment Modernization Act of 2015, provisions relating to payment and delivery reform
S. 810, SGR Repeal and Medicare Provider Payment Modernization Act of 2015, provisions relating to payment and delivery reform
H.R. 1190, Protecting Seniors' Access to Medicare Act of 2015, all provisions
S.141, Protecting Seniors' Access to Medicare Act of 2015, all provisions
H.R. 4442, Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act, provisions relating to telehealth
S. 2484, Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act, provisions relating to telehealth
S. 1131, Medicare Diabetes Prevention Act of 2015, all provisions
H.R. 2646, Helping Families in Mental Health Crisis Act of 2016, all provisions
S. 1945, Mental Health Reform Act of 2015, all provisions
S. 1913, Stopping Medication Abuse and Protecting Seniors Act of 2015, all provisions
Medicare program: MACRA Implementation
Medicare program: PAMA implementation
Medicare program: ACO Improvement Act
Medicare program: The Center for Medicare and Medicaid Innovation (CMMI)
Medicare program: Repeal of the Independent Payment Advisory Board (IPAB)
Medicare program: Medicare Part B Drug Demonstration
Medicare program: Regulatory Relief
Medicare program: CY 2017 Medicare Physician Fee Schedule
Medicare program: In-Office Ancillary Services Exception (IOASE)
Medicare program: Merit-Based Incentive Payment System (MIPS)
Medicare program: Value-Based Payment Modifier (VPM)
Medicare program: Physician Compare
Medicare program: Alternate Payment Models
Medicare program: Physician Quality Reporting System (PQRS)
Medicare program: Graduate Medical Education (GME)
Medicare program: Electronic Health Records/Meaningful Use (EHR/MU)
Medicare program: Quality Reporting
Medicare program: ICD-10
Medicare program: Prescription Drug Diversion
Medicare program: Physician data
Medicare program: Telemedicine
Medicare program: Patient Relationship Codes
Medicare program: Social Security Number Removal Initiative
Medicaid program: Amendment to New York's section 1115 demonstration waiver
Client expense: $3,990,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Medicare Payment Advisory Commission (MedPAC), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, Veterans Affairs, Dept of (VA), White House Office
Cited source text, amounts, lobbyists, and targets
National Diabetes Prevention Program; Better care and treatment of people with diabetes under P.L. 111-148 Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152 The Health Care & Education Affordability Reconciliation Act of 2010: Issues related to diabetes generally, and specifically diabetes screening, medical education and death certificate reporting (Catalyst for Better Diabetes), AHRQ and USPSTF diabetes screening standards; H.R. 1192 and S. 586 National Diabetes Clinical Care Commission Act of 2015; P.L. 114-10, Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) for Special Diabetes Program, CHIP, and childhood obesity; H.R. 1190 and S. 141 Protecting Seniors' Access to Medicare Act of 2015 (IPAB repeal); H.R. 2651 Eliminating Disparities in Diabetes Prevention, Access, and Care Act of 2015 (EDDPAC); cost of diabetes generally; S. 320 and H.R. 744 Medical Innovation Act of 2015; S. 2023 and H.R. 3513 Prescription Drug Affordability Act of 2015; H.R. 3742, Access to Marketplace Insurance Act and general allowance for certain third party payments of cost sharing; H.R. 6, 21st Century Cures Act.
Client expense: Not reported · Firm income: $60,000
Cited source text, amounts, lobbyists, and targets
Issues related to the prevention and treatment of lung disease. HR 1190 Protecting Seniors Access to Medicare Act of 2015; S. 1549 Care Planning Act of 2015;H.R. 670,the Special Needs Trust Fairness and Medicaid Improvement Act; Issues related to the Affordable Care Act; Issues related to Part B; Issues related to state Medicaid waivers; Issues related to lung cancer screening; Issues related to asthma; Issues related to tobacco cessation; Issues related to durable medical equipment; Issues related to the President's Budget; Issues related to the Budget Control Act;
Client expense: $50,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Council on Environmental Quality (CEQ), Defense, Dept of (DOD), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Housing & Urban Development, Dept of (HUD), Natl Institutes of Health (NIH), Navy, Dept of, Office of Management & Budget (OMB), SENATE, Treasury, Dept of, U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), White House Office
Cited source text, amounts, lobbyists, and targets
Issues related to the prevention and treatment of lung disease including the following legislation: H.R.6 21st Century Cures; H.R.531, Accelerating Biomedical Research Act; S.289, American Cures Act; S.318, Accelerating Biomedical Research Act; HR 1190 Protecting Seniors Access to Medicare Act of 2015; S. 1177 Every Child Achieves Act; S.1065 School Asthma Management Plan Act; S. 1064 Family Asthma Act; HR 2101 Research for All Act of 2015; S 2956 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017; HR 5054 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017; S 3040 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2017; H.R.5926 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2017; S 3000 Department of Defense Appropriations Act, 2017; HR 5293 Department of Defense Appropriations Act, 2017; S. 3117 Department of State, Foreign Operations, and Related Programs Appropriations Act, 2017; H.R.5912 Department of State, Foreign Operations, and Related Programs Appropriations Act, 2017; S 2837 Commerce, Justice, Science, and Related Agencies Appropriations Act, 2017; HR 5393 Commerce, Justice, Science, and Related Agencies Appropriations Act, 2017; S. 3068, Department of the Interior, Environment, and Related Agencies Appropriations Act, 2017; H.R.5538, Department of the Interior, Environment, and Related Agencies Appropriations Act, 2017; H.R.5394 Transportation, Housing and Urban Development, and Related Agencies Appropriations Act, 2017; S. 2844 Transportation, Housing and Urban Development, and Related Agencies Appropriations Act, 2017 HR 3762 Restoring Americans Healthcare Freedom Reconciliation Act of 2015; HR 3520 Pulmonary Hypertension Research and Diagnosis Act; HR 4662, School-Based Asthma Management Program Act; HR 5263, Women and Lung Cancer Research and Preventive Services Act of 2016; S.2941 - Women and Lung Cancer Research and Preventive Services Act of 2016;; HR 4662 School-Based Asthma Management Program Act; H.R. 4768, the Separation of Powers Restoration Act of 2016; HR 5263 Women and Lung Cancer Research and Preventive Services Act of 2016; S. 2624 National Biomedical Research Act; S. 2689 REGROW Act; HR 2028 Further Continuing and Security Assistance Appropriations Act, 2017; Issues related to Medicare and Medicaid reform; Issues related to Moonshot Initiative; Issues related to the Affordable Care Act; Issues related to Asthma, COPD, Influenza, Lung Cancer, Pneumonia, Tuberculosis and other lung diseases; Issues related to the President's Budget; Issues related to the Budget Control Act;
Client expense: $50,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Council on Environmental Quality (CEQ), Defense, Dept of (DOD), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Housing & Urban Development, Dept of (HUD), Natl Institutes of Health (NIH), Navy, Dept of, Office of Management & Budget (OMB), SENATE, Treasury, Dept of, U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), White House Office
Cited source text, amounts, lobbyists, and targets
RetireSafe worked as a leader, along with other patient advocate groups, to oppose any new cuts to the Medicare Advantage payment rates for 2016.
RetireSafe worked with the Medicare Access for Patients Rx Coalition (MAPRx) to raise concerns regarding the Advance Notice of Methodological Changes for Calendar Year 2016 for Medicare Advantage Capitation Rates, Part C and Part D Payment Policies and 2016 Call Letter to express concerns related to: the Exceptions and Appeals Process, Star Ratings and the Dual-Eligibles, Formulary Oversight, Drug Utilization Review Controls, Tier Labeling and Composition, Specialty Tiers, and the Use of Multiple Tiers with Coinsurance Cost-Sharing Rates.
RetireSafe joined with the Medicare Rights Center and other patient advocates to urge numerous changes to the Medicare Part D Program to make the Exceptions and Appeals Processes More Accessible for Beneficiaries.
RetireSafe joined with the Healthcare Leadership Council and others to support the Protecting Seniors Access to Medicare Act, (H.R. 1190 and S. 141) to repeal the Independent Payment Advisory Board (IPAB), authorized under the Patient Protection and Affordable Care Act.
Support H.R. 2624 and S. 1488, the Part D Beneficiary Appeals Fairness Act.
Support the passage of H.R. 160 to repeal the 2.3% Medical Device Tax.
Support the passage of H.R. 1190 to repeal the Independent Payment Advisory Board (IPAB).
Joined with the MAPRx coalition to urge Congress to build on the success of Medicare Part D to ensure robust formularies, coverage for the six-protected classes, strong oversight, and transparency for consumers, as well as add improvements to the process for notice of non-coverage, appeals and exceptions.
Also, urged Part D remedies to correct gaps in coverage, onerous cost-shifting created by specialty tiers, and restrictive utilization management tools that severely reduce patient benefits.
Support "340B" Medicaid program reform to end widespread abuse of the drug discount program that ultimately harms patients.
Joined with other patient advocate groups to comment on proposed rule: CMS-2390-P-Medicaid and Childrens Health Insurance Programs (CHIP); Medicaid Managed Care, CHIP Delivered in Managed Care, Medicaid and CHIP Comprehensive Quality Strategies, and Revisions Related to Third Party Liability. We supported the proposed rules intent to strengthen program integrity safeguards, and ensure beneficiary protections in areas of provider networks, coverage standards, and the treatment of appeals. We agree with the other groups that a modernized Medicaid managed care regulatory structure is essential to facilitate necessary system reform initiatives, and advance the delivery of health care for millions of people, and we supported rule changes to achieve those goals.
RetireSafe joined with other patient advocates to comment on proposed rule: CMS-1631-P-Medicare Program; Revisions to Payment Policies under the Physician Fee Schedule and Other Revisions to Part B for CY2016. In commenting we supported various measures for improving accuracy for primary care and care management services; providing appropriate advanced care planning services; providing better Medicare Tele-health services; providing better Chronic Care Management services for Rural Health Clinics and Qualified Health Centers; providing a useful Physicians Compare Website with data in proper context; and providing physician payment, efficiency, and quality improvements linked to a physician quality reporting system.
RetireSafe joined with numerous patient groups to oppose a new CMS plan to cut the payment rate (from Average Sales Price plus 6%) for Medicare Part B Drugs administered by physicians in large parts of the U.S. because this Center for Medicare & Medicaid initiative focuses on costs rather than patients needs and health care quality. This new Part B Drug Plan will adversely impact Medicare patients with complex conditions such as cancer, macular degeneration, hypertension, rheumatoid arthritis, and primary immunodeficiency diseases.
Along with many other patient advocates in the MAPRx Coalition, we strongly opposed a recent MedPAC effort to place Medicare cost savings ahead of the best interests of Medicare patients. Specifically, we urged MedPAC to reject proposals to make changes to true out-of-pocket costs (TrOOP); increase copays for low-income subsidy (LIS) beneficiaries; and eliminate any of the protected classes.
RetireSafe joined with numerous patient groups to comment on the CMS Advance Notice and Draft Call Letter issued on February 19, 2016. The comments focused on better patient access to Medicare Part D Prescription Drugs and related specifically to: Specialty Tier Thresholds, Tier Labeling and Composition, Generic Tier $0 Copay Plans, Formulary Oversight, Drug Utilization Review Controls, Coverage Determination Timelines, and Access to Preferred Cost-sharing Pharmacies.
RetireSafe has continued to work with a large number of patient groups (on several occasions) to strongly oppose the Centers for Medicare Services (CMS) Centers for Medicare and Medicaid Innovation (CMMI) March 8, 2016 proposed rule that would implement substantial changes to the Medicare Part B payment program. As we have stated in several joint letters to Members of Congress and to CMS, we believe the proposed changes which have been proposed as a demonstration project would impact some 75 percent of Medicare population and could limit access to the full range of available treatments under Part B to treat serious illnesses and medical treatments such as cancer, multiple sclerosis, primary immune deficiency, macular degeneration and schizophrenia. Unfortunately, the proposed program will be, in fact, mandatory for many physicians and their patients, and will cause patients to switch from the most appropriate treatment to less effective therapies or to forego treatment altogether because of transportation hurdles created by the new rule. RetireSafe also objects to the lack of sufficient stakeholder input from the beginning of this rule-making process, which has now created one-size-fits-all government payment policies that ignore patient differences and completely undermines the goal of patient-centered Medicare.
Client expense: Not reported · Firm income: $11,560
Cited source text, amounts, lobbyists, and targets
RetireSafe worked as a leader, along with other patient advocate groups, to oppose any new cuts to the Medicare Advantage payment rates for 2016.
RetireSafe worked with the Medicare Access for Patients Rx Coalition (MAPRx) to raise concerns regarding the Advance Notice of Methodological Changes for Calendar Year 2016 for Medicare Advantage Capitation Rates, Part C and Part D Payment Policies and 2016 Call Letter to express concerns related to: the Exceptions and Appeals Process, Star Ratings and the Dual-Eligibles, Formulary Oversight, Drug Utilization Review Controls, Tier Labeling and Composition, Specialty Tiers, and the Use of Multiple Tiers with Coinsurance Cost-Sharing Rates.
RetireSafe joined with the Medicare Rights Center and other patient advocates to urge numerous changes to the Medicare Part D Program to make the Exceptions and Appeals Processes More Accessible for Beneficiaries.
RetireSafe joined with the Healthcare Leadership Council and others to support the Protecting Seniors Access to Medicare Act, (H.R. 1190 and S. 141) to repeal the Independent Payment Advisory Board (IPAB), authorized under the Patient Protection and Affordable Care Act.
Support H.R. 2624 and S. 1488, the Part D Beneficiary Appeals Fairness Act.
Support the passage of H.R. 160 to repeal the 2.3% Medical Device Tax.
Support the passage of H.R. 1190 to repeal the Independent Payment Advisory Board (IPAB).
Joined with the MAPRx coalition to urge Congress to build on the success of Medicare Part D to ensure robust formularies, coverage for the six-protected classes, strong oversight, and transparency for consumers, as well as add improvements to the process for notice of non-coverage, appeals and exceptions.
Also, urged Part D remedies to correct gaps in coverage, onerous cost-shifting created by specialty tiers, and restrictive utilization management tools that severely reduce patient benefits.
Support "340B" Medicaid program reform to end widespread abuse of the drug discount program that ultimately harms patients.
Joined with other patient advocate groups to comment on proposed rule: CMS-2390-P-Medicaid and Childrens Health Insurance Programs (CHIP); Medicaid Managed Care, CHIP Delivered in Managed Care, Medicaid and CHIP Comprehensive Quality Strategies, and Revisions Related to Third Party Liability. We supported the proposed rules intent to strengthen program integrity safeguards, and ensure beneficiary protections in areas of provider networks, coverage standards, and the treatment of appeals. We agree with the other groups that a modernized Medicaid managed care regulatory structure is essential to facilitate necessary system reform initiatives, and advance the delivery of health care for millions of people, and we supported rule changes to achieve those goals.
RetireSafe joined with other patient advocates to comment on proposed rule: CMS-1631-P-Medicare Program; Revisions to Payment Policies under the Physician Fee Schedule and Other Revisions to Part B for CY2016. In commenting we supported various measures for improving accuracy for primary care and care management services; providing appropriate advanced care planning services; providing better Medicare Telehealth services; providing better Chronic Care Management services for Rural Health Clinics and Qualified Health Centers; providing a useful Physicians Compare Website with data in proper context; and providing physician payment, efficiency, and quality improvements linked to a physician quality reporting system.
RetireSafe joined with numerous patient groups to oppose a new CMS plan to cut the payment rate (from Average Sales Price plus 6%) for Medicare Part B Drugs administered by physicians in large parts of the U.S. because this Center for Medicare & Medicaid initiative focuses on costs rather than patients needs and health care quality. This new Part B Drug Plan will adversely impact Medicare patients with complex conditions such as cancer, macular degeneration, hypertension, rheumatoid arthritis, and primary immunodeficiency diseases.
Along with many other patient advocates in the MAPRx Coalition, we strongly opposed a recent MedPAC effort to place Medicare cost savings ahead of the best interests of Medicare patients. Specifically, we urged MedPAC to reject proposals to make changes to true out-of-pocket costs (TrOOP); increase copays for low-income subsidy (LIS) beneficiaries; and eliminate any of the protected classes.
RetireSafe joined with numerous patient groups to comment on the CMS Advance Notice and Draft Call Letter issued on February 19, 2016. The comments focused on better patient access to Medicare Part D Prescription Drugs and related specifically to: Specialty Tier Thresholds, Tier Labeling and Composition, Generic Tier $0 Copay Plans, Formulary Oversight, Drug Utilization Review Controls, Coverage Determination Timelines, and Access to Preferred Cost-sharing Pharmacies.
RetireSafe has continued to work with a large number of patient groups (on several occasions) to strongly oppose the Centers for Medicare Services (CMS) Centers for Medicare and Medicaid Innovation (CMMI) March 8, 2016 proposed rule that would implement substantial changes to the Medicare Part B payment program. As we have stated in several joint letters to Members of Congress and to CMS, we believe the proposed changes which have been proposed as a demonstration project would impact some 75 percent of Medicare population and could limit access to the full range of available treatments under Part B to treat serious illnesses and medical treatments such as cancer, multiple sclerosis, primary immune deficiency, macular degeneration and schizophrenia. Unfortunately, the proposed program will be, in fact, mandatory for many physicians and their patients, and will cause patients to switch from the most appropriate treatment to less effective therapies or to forego treatment altogether because of transportation hurdles created by the new rule. RetireSafe also objects to the lack of sufficient stakeholder input from the beginning of this rule-making process, which has now created one-size-fits-all government payment policies that ignore patient differences and completely undermines the goal of patient-centered Medicare.
Client expense: Not reported · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Cited source text, amounts, lobbyists, and targets
Legislation and policies related to:
Physician/nurse practitioner reimbursement
Provisions of the Patient Protection & Affordable Care Act (P.L. 111-148)
Adoption of recommendations of the Institute of Medicine report, The Future of Nursing: Leading Change, Advancing Health
Medicare Shared Savings Program beneficiary assignment requirements
Medicare-Medicaid hospital conditions of participation
Evaluation of the Medicare Graduate Nurse Education demonstration
Medicare-Medicaid Program Integrity policies
Medicaid maintenance of effort requirements
Medicaid eligibility expansion and state options
Medicaid waiver application procedures
Medicaid per capita cap policy options
Medicare-Medicaid dual eligible coverage and demonstration
Draft Hospital Improvement for Payment (HIP) Act
HHS study on the comparability of CHIP coverage and benefits with those of marketplace health plans
Medicare provisions of H.R. 1892, the Trade Adjustment Assistance Act
H.R. 2 - Medicare Access and CHIP Reauthorization Act
H.R. 160/S. 149 - Protect Medical Innovation Act
H.R. 546/S. 298 - Advancing Care for Exceptional Kids (ACE Kids) Act
H.R. 700 - Stabilize Medicaid and CHIP Coverage Act
H.R. 818/S. 861 - Preventing and Reducing Improper Medicare and Medicaid Expenditures (PRIME) Act
H.R. 876 - Notice of Observation Treatment and Implication for Care Eligibility (NOTICE) Act
H.R. 919 - CHIP Extension and Improvement Act
H.R. 1021 - Protecting Integrity of Medicare Act (PIMA)
H.R. 1190/S. 141 - Protecting Seniors Access to Medicare Act
H.R. 1362 - Medicaid Requiring Expenditures for Public Objectives to be Reflective of Total Spending (Medicaid REPORTS) Act
H.R. 1458 - Bundling and Coordinating Post-Acute Care (BACPAC) Act
H.R. 1470 - SGR Repeal and Medicare Provider Payment Modernization Act
H.R. 2339 - To amend title XIX of the Social Security Act to clarify the treatment of lottery winnings and other lump sum income for purposes of income eligibility under the Medicaid program
H.R. 3014 - Medical Controlled Substances Transportation Act
H.R. 3134 - Defund Planned Parenthood Act of 2015
H.R. 3292 - Medicare IME Pool Act
H.R. 3298 - Medicare Post-Acute Care Value-Based Purchasing Act
H.R. 3716 - Ensuring Terminated Providers Are Removed From Medicaid and CHIP Act
H.R. 3821/S. 2618 - Medicaid Directory of Caregivers (Medicaid DOC) Act
H.R. 4588 - Incentivizing Medicaid Expansion Act of 2016
H.R. 4725 - Common Sense Savings Act of 2016
H.R. 5164 - Rural Hospital Regulatory Relief Act
H.R. 5122 - To prohibit further action on the proposed rule regarding testing of Medicare part B prescription drug models
H.R. 5210/S. 2736 - Patient Access to Durable Medical Equipment Act
H.R. 5273 - Helping Hospitals Improve Patient Care Act of 2016
H.R. 5613/S. 3129 - Continuing Access to Hospitals Act of 2016
S. 257/H.R. 1611 - Protecting Access to Rural Therapy Services Act
S. 578/H.R. 1342 - Home Health Care Planning Improvement Act
S. 737/H.R. 2253 - Ensuring Access to Primary Care for Women & Children Act
S. 1349 - Notice of Observation Treatment and Implication for Care Eligibility (NOTICE) Act
S. 1456 - Rural ACO Improvement Act
S. 1461 - Extending a moratorium on enforcement of direct physician supervision of outpatient therapeutic services in critical access and small rural hospitals through 2015
S. 2425 - Patient Access and Medicare Protection Act
S. 2787 - States Achieve Medicaid Expansion (SAME) Act
S. 3130 - Independence at Home Act of 2016
Client expense: Not reported · Firm income: $23,450
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Medicare Payment Advisory Commission (MedPAC), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, Veterans Affairs, Dept of (VA), White House Office
Cited source text, amounts, lobbyists, and targets
Issues relating to implementation of legislative or regulatory changes to Medicare and Medicaid, including Medicare Part B drug reimbursement. Issues before CMS relating to Medicare payment for preventive screening, coordinated patient care, care planning; H.R.1220 & S.624, Removing Barriers to Colorectal Cancer Screening Act; and H.R.1190, Protecting Seniors' Access to Medicare Act and issues relating to CMS-issued regulations pertaining to Medicare Part B reimbursement, regulations relating to the Medicare Access and CHIP Reauthorization Act of 2015.
Client expense: $1,620,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), White House Office
Cited source text, amounts, lobbyists, and targets
HR1190, Protecting Seniors' Access to Medicare Act of 2015 (all sections of full text)
S141, Protecting Seniors' Access to Medicare Act of 2015 (all sections of full text)
S.2680 Mental Health Reform Act of 2016 (all sections of full text)
S.1945 Mental Health Reform Act of 2015 (all sections of full text)
Monitored the HHS/CMS 'Two-Midnight' rule-making process and decision on inpatient payments
Monitored HR1083, Medicaid Physician Self-Referral Act of 2015 (All sections of full text)
Monitored HR4273 Medicare and Medicaid Improvements and Adjustments Act of 2015; monitored the lowering of Medicare outpatient site neutral rate proposals
Monitored HR4428 Fair Medicare Hospital Payments Act of 2016
Monitored HR5273 Helping Hospitals Improve Patient Care Act of 2016
Monitored HR 5547 Health Care Price Transparency Promotion Act of 2016
Client expense: Not reported · Firm income: $40,000
Cited source text, amounts, lobbyists, and targets
Support for provisions in 21st Century Cures Act (H.R. 34), including establishment of a socio-economic status (SES) risk adjuster for the Medicare Readmissions Reduction Program; changes to site-neutral payment provision of Bipartisan Budget Act of 2015 (P.L. 114-74) and flexibility in implementation of Section 603 of the law; non-enforcement of the direct supervision rules for CAHs; NIH, mental health, and opioid crisis provisions and funding
Protecting 340B Drug Pricing Program in regulatory and legislative proposals
Support for changes to liver transplant allocation system
Urging modifications to Hospital Compare Star Rating System
Support for Standard Merger and Acquisition Reviews Through Equal Rules (SMARTER) Act (H.R. 2745)
Addressing concerns related to the Physician Quality Reporting System (PQRS) and reporting mechanisms
Encouraging Committees of jurisdiction to examine overlap in Merit-based Incentive Payment System and Medicare and Medicaid Electronic Health Record Incentive Payment Programs (Meaningful Use)
Urging further flexibility in proposed rule [CMS-5517-P] to implement Medicare Access and CHIP Reauthorization Act of 2015 (MACRA)
Opposition to redistribution of Medicare DSH payments proposed in FFY 2017 Inpatient Prospective Payment System (IPPS) rule [CMS-1655-P]
Support for Protecting Seniors Access to Medicare Act of 2015 (H.R. 1190 and S.141)
Support for Rural Hospital Access Act of 2015 (H.R. 663/S. 332)
Support for Critical Access Hospital Relief Act of 2015 (H.R. 169/S. 258)
Support for Protecting Access to Rural Therapies Act (H.R. 1611/S. 257)
Support for Resident Physician Shortage Reduction Act of 2015 (H.R. 2124/ S. 1148)
Support for Medicare Audit Improvement Act of 2015 (H.R. 2156)
Support for Craig Thomas Rural Hospital and Provider Equity Act (S. 2359)
Support for Making the Education of Nurses Dependable for Schools (MEND) Act (H.R. 5227)
Support for emergency funding to address Zika outbreak
Encouraging Administration to engage hospital and health system field in discussions to address cybersecurity challenges.
Client expense: $110,000 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
Issues relating to implementation of legislative or regulatory changes to Medicare and Medicaid, including Medicare Part B drug reimbursement. Issues before CMS relating to Medicare payment for preventive screening, coordinated patient care, care planning; H.R.1220 & S.624, Removing Barriers to Colorectal Cancer Screening Act; and H.R.1190, Protecting Seniors' Access to Medicare Act and issues relating to CMS-issued regulations pertaining to Medicare Part B reimbursement, regulations relating to the Medicare Access and CHIP Reauthorization Act of 2015.
Client expense: $1,630,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), White House Office
Cited source text, amounts, lobbyists, and targets
National Diabetes Prevention Program; Better care and treatment of people with diabetes under P.L. 111-148 Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152 The Health Care & Education Affordability Reconciliation Act of 2010: Issues related to diabetes generally, and specifically diabetes screening, medical education and death certificate reporting (Catalyst for Better Diabetes), AHRQ and USPSTF diabetes screening standards; diabetes issues in Healthy People 2020 and the Office of Disease Prevention and Health Promotion (ODPHP); H.R. 1192 and S. 586 National Diabetes Clinical Care Commission Act of 2015; P.L. 114-10, Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) for Special Diabetes Program, CHIP, and childhood obesity; S. 84 and H.R. 3658 Gestational Diabetes Act of 2015; H.R. 1190 and S. 141 Protecting Seniors' Access to Medicare Act of 2015 (IPAB repeal); H.R. 2651 Eliminating Disparities in Diabetes Prevention, Access, and Care Act of 2015 (EDDPAC); cost of diabetes generally; S. 320 and H.R. 744 Medical Innovation Act of 2015; S. 2023 and H.R. 3513 Prescription Drug Affordability Act of 2015; H.R. 3742, Access to Marketplace Insurance Act and general allowance for certain third party payments of cost sharing; Congressional recognition of World Hemophilia Day and Growth Awareness Week.
Client expense: $262,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Indian Health Service, Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, Treasury, Dept of
Government targets: Administration for Children & Families (ACF), Agency for Healthcare Research & Quality (AHRQ), Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Environmental Protection Agency (EPA), Equal Employment Opportunity Commission (EEOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Indian Health Service, Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Natl Drug Control Policy (NDCP), SENATE, U.S. Agency for International Development (USAID), Veterans Affairs, Dept of (VA), White House Office
Cited source text, amounts, lobbyists, and targets
H.R. 1707, Access to Frontline Health Care Act, all sections
H.R. 1741, Truth in Health Marketing Act, all sections
H.R. 1190, Protecting Seniors Access to Medicare Act, all sections
S. 141, Protecting Seniors Access to Medicare Act, all sections
P.L. 111-192, Preservation of Access to Care for Medicare Beneficiaries and Pension Relief Act of 2010, all sections related to physicians and vision
P.L. 111-148 Affordable Care Act, modifications:
1. Reducing regulatory/costly burdens on medical practices - relief from regulatory penalties
2. Preserving patient access to office ancillary testing services
4. Independent Payment Advisory Board
H.R. 1312, National Health Service Corps Improvement Act
Meaningful Use/EHR program issues
P.L. 113-54, Drug Quality & Security Act, all sections
Protecting Access to Medicare Act (P.L. 113-93)
ASC Quality Reporting Program
Medicare Advantage plan network adequacy
H.R. 270, FlexIT Act, all sections
H.R. 3309, Flex IT 2 Act, all sections
S. 2141, Trust IT Act
2016 Physician Schedule Rule, sections pertaining to fee cuts
Drug Price Increases
Medicare Part B Drug Demonstration
Medicare Access and CHIP Reauthorization Act (PL114-10)
S.2777, Contact Lens Consumer Health Protection Act
H.R. 6, 21st Century Cures
Proposed 2017 Physician Fee Schedule. Section pertaining to global surgery data collection proposal
H.R. 1178, Ensuring Equal Access to Treatment Act
Client expense: $160,000 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
H.R. 1416, Cancer Patient Protection Act, regarding all biopharmaceutical related provisions.
H.R. 1190 and S. 41, Protecting Seniors' Access to Medicare Act, regarding all biopharmaceutical related provisions.
H.R. 2, Medicare Access and CHIP Authorization Act, regarding all biopharmaceutical related provisions
H.R. 2570, Strengthening Medicare Advantage through Innovation and Transparency for Seniors Act, regarding all biopharmaceutical related provisions.
No Bill, lobbied on price controls for biopharmaceuticals in government health care programs.
No Bill, lobbied on the proposed rule on the CMMI Medicare Part B demonstration project.
H.R. 5122, legislation to prohibit further action on the proposed rule regarding testing of Medicare part B prescription drug models,regarding all biopharmaceutical related provisions.
Client expense: $560,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR)
Cited source text, amounts, lobbyists, and targets
Implementation/Expansion of CDC Falls Program
Implementation of Affordable Care Act - provisions pertaining to Essential Health Benefits & Health Insurance Exchanges
AHRQ provisions pertaining to PT
H.R. 582/S. 307 ConTACT Act
H.R. 1383 Medicare Adult Day Services Act
H.R. 263 Adult Day Care Enhancement Act
H.R. 1707 Access to Frontline Healthcare Act
H.R. 395/S. 536 Indian Health Service Health Professionals Tax Fairness Act
H.R. 2 SGR Repeal
Physician self-referra/Stark Law
American Cures Act
H.R. 1608/S. 2373 Lymphadema Treatment Act
Health Information Technology
Nominations to PCORI Methodology Committees
H.R. 1190/S. 141 IPAB repeal
H.R. 1741 Truth In Healthcare Marketing Act
Medicaid Expansion
HR. 2342/S. 1426 Physical Therapist Workforce & Patient Access Act
Physician owned distributerships
H.R. 921/S. 689 Sports Medicine Licensure Clarity Act
S. 2364 Medicare Home Health Flexibility Act
MACRA/MIPS
APMS
IMPACT/PAC reform
Network adequacy
Insurance Benefit parameters
H.R. 4641 To provide for the establishment of an inter-agency task force to review, modify, and update best practices for pain management and prescribing pain medication, and for other purposes.
S. 524/H.R. 953 Comprehensive Addiction & Recovery Act of 2015
H.R. 5088 PIMA
H.R. 5045 Preserving Access to Modern Prosthetic Limbs Act of 2016
H.R. 4266 Nurse & Health Care Worker Protection Act
H.R. 1516 Ensuring Access to Quality CRT
H.R. 1530 Medicare O&P Improvement Act
H.R. 1420 National TBI Research & Treatment Improvement Act
H.R. 2948 Medicare Telehealth Parity Act of 2015
S. 800/H.R. 1631 Enhancing the Stature and Visibility of Medicare Research at NIH Act
Client expense: $258,406 · Firm income: Not reported
Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Education, Dept of, Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Medicare Payment Advisory Commission (MedPAC), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, Small Business Administration (SBA), Veterans Affairs, Dept of (VA), White House Office
Cited source text, amounts, lobbyists, and targets
PL 109-442: Lifespan Respite Care Act; PL 109-365: Older Americans Act Amendments of 2006; PL 111148: The Patient Protection and Affordable Care Act; PL 111-152: Affordable Health Care for America Act; PHS 42 USC 254C-8: Healthy Start Reauthorization of 2007; PL 111-192: Preservation of Access to Care for Medicare Beneficiaries and Pension Relief Act; PL 111-152, 124 Stat. 1029: Health Care & Education Reconciliation Act; HR 1190: Protecting Seniors Access to Medicare; S 810: Repeal Outpatient Rehab Caps; HR 928/S 408: Medicare Prescription Drug Savings & Choice Act; HR 132: ObamaCare Repeal Act; S 1034/HR 1960: National Defense Authorization Act 2014; S 737/HR 1516: Ensuring Access to Quality Complex Rehabilitation Technology Act of 2013; S 2449/HR 4631: Autism CARES (Collaboration, Accountability, Research, Education and Support) Act of 2014; S 192: Older Americans Act Reauthorization Act of 2015; HR 30: Save American Workers Act; HR 2: Medicare Access & CHIP Reauthorization Act; S 157: No Obama Mandate Act; HR 1271: Concussion Awareness & Education Act; HR 1470: SGR Repeal & Medicare Provider Payment Modernization Act; HR 160: Protecting Medical Innovations Act; S 539/HR 775: Medicare Access to Rehabilitation Services Act; HR 2646: Helping Families in Mental Health Crisis: HR 5003: Improving Child Nutrition and Education Act of 2016; HR 5243: Zika Response Appropriation Act of 2016; HR 1859: Ensuring Children's Access to Specialty Care Act of 2015; and HR 5325: Continuing Appropriations and Military Construction, Veterans Affairs Act of 2017 and Zika Response and Preparedness Act.
Client expense: $41,529 · Firm income: Not reported
Government targets: Administration for Children & Families (ACF), Defense, Dept of (DOD), Education, Dept of, Equal Employment Opportunity Commission (EEOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Justice, Dept of (DOJ), Labor, Dept of (DOL), Natl Council on Disability, SENATE, Transportation, Dept of (DOT), U.S. Architectural & Transportation Barriers Compliance Board (ACCESS), Veterans Affairs, Dept of (VA), White House Office
Cited source text, amounts, lobbyists, and targets
H.R. 3762, Restoring Americans Healthcare Freedom Reconciliation Act
H.R. 592/S. 314, Pharmacy and Medically Underserved Areas Enhancement Act
H.R. 954, CO-OP Consumer Protection Act of 2016
H.R. 1190/S. 141, The Protecting Seniors Access to Medicare Act of 2015
H.R. 1192, National Clinical Care Commission Act
H.R. 1270, Restoring Access to Medication and Improving Health Savings Act
H.R. 1427, Medicare CGM Access Act
H.R. 1686/S. 3082, Preventing Diabetes in Medicare Act
H.R. 1707, Access to Frontline Health Care Act of 2015
H.R. 1726, Access to Quality Diabetes Education Act
H.R. 1807, Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2015
H.R. 2102, Medicare Diabetes Prevention Act
H.R. 2124/S. 1148, Resident Physician Shortage Act
H.R. 2603/S. 1475, Saving Lives, Saving Costs Act
H.R. 2646, Helping Families in Mental Crisis Act
H.R. 2713/S. 3245, Title VIII Nursing Workforce Reauthorization Act of 2016
H.R. 3081/S. 1778, Telemedicine for Medicare Act
H.R. 3119/S. 2748, Palliative Care and Hospice Education and Training Act
H.R. 3660/S. 3126,Preventive Health Savings Act
H.R. 3952/S. 2248, Congenital Heart Future Reauthorization Act of 2015
H.R. 4212/S. 704, Community Based Independence for Seniors Act of 2015
H.R. 4442/S. 2484, CONNECT for Health Act
H.R. 4732/S. 2671, Advancing Medical Resident Training in Community Hospitals Act
H.R. 4774, Training Tomorrows Doctors Today Act
H.R. 4909/S. 2943, National Defense Authorization Act
H.R. 5273, Helping Hospitals Improve Patient Care Act
H.R. 5414, FDA Cross-Center Collaboration Act
H.R. 5447/S. 3060, The Small Business Health Care Relief Act
H.R. 5652,Access to Better Care Act
H.R. 5681/S. 3137, Alzheimers Beneficiary and Caregiver Support Act
H.R. 5713, Sustaining Healthcare Integrity and Fair Treatment Act of 2016
H.R.5926 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2017
H.R. 6043/S. 3335, The Fair Accountability and Innovative Research Drug Pricing Act of 2016
H.R. 6109/S. 3371, Medicare Affordability and Enrollment Act
S. 524, Comprehensive Addiction and Recovery Act
S. 586, National Diabetes Clinical Care Commission Act
S. 603, Jobs and Premium Protection Act
S. 776,Medication Therapy Management Empowerment Act
S. 1077,Advancing Breakthrough Medical Devices for Patients Act
S. 1101,Medical Electronic Data Technology Enhancement for Consumers Health (MEDTECH) Act
S. 1622,FDA Device Accountability Act
S. 2511,Improving Health Information Technology Act
S. 2680,Mental Health Reform Act of 2016
S. 2864,Reducing Existing Costs Associated with Pharmaceuticals for Seniors Act of 2016
S. 3326,State Flexibility to Provide Affordable Health Options Act
S. 3504, Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2016
Pub. L. 111-5, The American Recovery and Reinvestment Act of 2009 (Health Information Technology for Economic and Clinical Health Act (HITECH)
Pub. L. 111-148, Patient Protection and Affordable Care Act (PPACA)
Pub. L. 114-10, Medicare Access and CHIP Reauthorization Act (MACRA)
Pub. L. 114-255,21st Century Cures
Pub. L. 114-270, Expanding Capacity for Health Outcomes Act (ECHO)
Pub. L. 114-328, National Defense Authorization Act for Fiscal Year 2017
Client expense: $150,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Cited source text, amounts, lobbyists, and targets
H.R. 1190/S. 141, The Protecting Seniors Access to Medicare Act of 2015
H.R. 1270, Restoring Access to Medication and Improving Health Savings Act
H.R. 1427, Medicare CGM Access Act
H.R. 1686/S. 3082, Preventing Diabetes in Medicare Act
H.R. 1707, Access to Frontline Health Care Act of 2015
H.R. 1726, Access to Quality Diabetes Education Act
H.R. 2102, Medicare Diabetes Prevention Act
H.R. 2124/S. 1148, Resident Physician Shortage Act
H.R. 2603/S. 1475, Saving Lives, Saving Costs Act
H.R. 3119/S. 2748, Palliative Care and Hospice Education and Training Act
H.R. 3660/S. 3126,Preventive Health Savings Act
H.R. 3952/S. 2248, Congenital Heart Future Reauthorization Act of 2015
H.R. 4212/S. 704, Community Based Independence for Seniors Act of 2015
H.R. 5273, Helping Hospitals Improve Patient Care Act
H.R. 5681/S. 3137, Alzheimers Beneficiary and Caregiver Support Act
H.R.5926 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2017
H.R. 6043/S. 3335, The Fair Accountability and Innovative Research Drug Pricing Act of 2016
H.R. 6109/S. 3371, Medicare Affordability and Enrollment Act
S. 776,Medication Therapy Management Empowerment Act
S. 1077,Advancing Breakthrough Medical Devices for Patients Act
S. 1101,Medical Electronic Data Technology Enhancement for Consumers Health (MEDTECH) Act
S. 2864,Reducing Existing Costs Associated with Pharmaceuticals for Seniors Act of 2016
S. 3326,State Flexibility to Provide Affordable Health Options Act
Pub. L. 111-5, The American Recovery and Reinvestment Act of 2009 (Health Information Technology for Economic and Clinical Health Act (HITECH)
Pub. L. 114-10, Medicare Access and CHIP Reauthorization Act (MACRA)
Pub. L. 114-255,21st Century Cures
Client expense: $150,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Government targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Natl Institutes of Health (NIH), Occupational Safety & Health Administration (OSHA), Office of Management & Budget (OMB), SENATE, Veterans Affairs, Dept of (VA)
Cited source text, amounts, lobbyists, and targets
H.R.1190, Protecting Seniors Access to Medicare Act of 2015 (all sections of full text)
S.141, Protecting Seniors Access to Medicare Act of 2015 (all sections of full text)
S. 2680 Mental Health Reform Act of 2016 (all sections of full text)(support)
S.1945 Mental Health Reform Act of 2015 (all sections of full text)(support)
Monitored the HHS/CMS 'Two-Midnight' rule-making process and decision on inpatient payments
Monitored H.R.1083, Medicaid Physician Self-Referral Act of 2015 (all sections of full text)
Monitored H.R. 4273 Medicare and Medicaid Improvements and Adjustments Act of 2015; monitored the lowering of Medicare outpatient site neutral rate proposals
Monitored H.R. 4428 Fair Medicare Hospital Payments Act of 2016
Monitored H.R. 5273 Helping Hospitals Improve Patient Care Act of 2016
Monitored H.R. 5547 Heath Care Price Transparency Promotion Act of 2016
Client expense: Not reported · Firm income: $130,000
Cited source text, amounts, lobbyists, and targets
Medicare Physician Payment Reform - implementation of Medicare Access and CHIP Reauthorization Act (MACRA) of 2015
Health Care Reform - implementation of the Patient Protection and Affordable Care Act of 2009
Repeal of the Independent Payment Advisory Board, H.R. 1190/S. 141
Meaningful Use of EHRs - Further Flexibility in HIT Reporting and Advancing Interoperability Act, H.R. 3309
Protect Continuing Education and Patient Care Act, H.R. 293
Comments submitted to CMS on 2017 Medicare Physician Fee Schedule and Hospital Outpatient Prospective Payment System Final Rules
21st Century Cures Act, H.R. 34
Client expense: $80,000 · Firm income: Not reported
Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Cited source text, amounts, lobbyists, and targets
General Medicare Protection, Repeal of Sustainable Growth Rate Formula, Prevention of Fraud, Waste, and Abuse: H.R. 818, Repeal of Independent Payment Advisory Board: H.R. 1190 and S. 141, Prescription Drug Re-Importation: S. 122, Negotiation of Prescription Drug Prices: S. 31 and H.R. 3061 and H.R. 3513 and S. 2023, Prevention of Catastrophic Spending on Prescription Drugs: S. 2864.
Client expense: Not reported · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
H.R. 2646 - Helping Families in Mental Health Crisis Act of 2015
H.R. 2 - Medicare Access and CHIP Reauthorization Act of 2015
H.R. 6 - 21st Century Cures Act
S. 711 - Mental Health First Act of 2015
S. 599 - Improving Access to Emergency Psychiatric Care Act
S. 149 - Medical Device Access and Innovation Protection Act
H.R. 160 - Protect Medical Innovation Act of 2015
H.R. 1190 - Protecting Seniors' Access to Medicare Act of 2015
S. 141 - Protecting Seniors Access to Medicare Act of 2015
H.R.3762 - Restoring Americans' Healthcare Freedom Reconciliation Act of 2015
S. 1945 - Mental Health Reform Act of 2015
S. 2680 - Mental Health Reform Act of 2016
S. 524 - Comprehensive Addiction and Recovery Act (CARA)
Client expense: Not reported · Firm income: $50,000
Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Executive Office of the President (EOP), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), SENATE
Cited source text, amounts, lobbyists, and targets
H.R. 2646 - Helping Families in Mental Health Crisis Act of 2015
H.R. 2 - Medicare Access and CHIP Reauthorization Act of 2015
H.R. 6 - 21st Century Cures Act
S. 711 - Mental Health First Act of 2015
S. 599 - Improving Access to Emergency Psychiatric Care Act
S. 149 - Medical Device Access and Innovation Protection Act
H.R. 160 - Protect Medical Innovation Act of 2015
H.R. 1190 - Protecting Seniors' Access to Medicare Act of 2015
S. 141 - Protecting Seniors Access to Medicare Act of 2015
H.R.3762 - Restoring Americans' Healthcare Freedom Reconciliation Act of 2015
S. 1945 - Mental Health Reform Act of 2015
S. 2680 - Mental Health Reform Act of 2016
S. 524 - Comprehensive Addiction and Recovery Act (CARA)
Client expense: Not reported · Firm income: $50,000
Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Executive Office of the President (EOP), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), SENATE
Cited source text, amounts, lobbyists, and targets
H.R. 2 - Medicare Access and CHIP Reauthorization Act of 2015
H.R. 6 - 21st Century Cures Act
S. 995 - Bipartisan Congressional Trade Priorities and Accountability Act of 2015
H.R. 2581 - Preservation of Access for Seniors in Medicare Advantage Act of 2015
S. 149 - Medical Device Access and Innovation Protection Act
H.R. 160 - Protect Medical Innovation Act of 2015
H.R. 2156 - Medicare Audit Improvement Act of 2015
S. 1268 - Trade Adjustment Assistance Reauthorization Act of 2015
H.R. 1295 - Trade Preferences Extension Act of 2015
H.R. 1190 - Protecting Seniors' Access to Medicare Act of 2015
S. 141 - Protecting Seniors Access to Medicare Act of 2015
H.R.3762 - Restoring Americans' Healthcare Freedom Reconciliation Act of 2015
S.754 - Cybersecurity Information Sharing Act of 2015
Client expense: Not reported · Firm income: $40,000
Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Executive Office of the President (EOP), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), SENATE
Cited source text, amounts, lobbyists, and targets
H.R. 2 - Medicare Access and CHIP Reauthorization Act of 2015
H.R. 6 - 21st Century Cures Act
S. 995 - Bipartisan Congressional Trade Priorities and Accountability Act of 2015
H.R. 2581 - Preservation of Access for Seniors in Medicare Advantage Act of 2015
S. 149 - Medical Device Access and Innovation Protection Act
H.R. 160 - Protect Medical Innovation Act of 2015
H.R. 2156 - Medicare Audit Improvement Act of 2015
S. 1268 - Trade Adjustment Assistance Reauthorization Act of 2015
H.R. 1295 - Trade Preferences Extension Act of 2015
H.R. 1190 - Protecting Seniors' Access to Medicare Act of 2015
S. 141 - Protecting Seniors Access to Medicare Act of 2015
H.R.3762 - Restoring Americans' Healthcare Freedom Reconciliation Act of 2015
S.754 - Cybersecurity Information Sharing Act of 2015
Client expense: Not reported · Firm income: $40,000
Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Executive Office of the President (EOP), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), SENATE
Cited source text, amounts, lobbyists, and targets
Issues surrounding the enactment or repeal of the Affordable Care Act, including IPAB and ACOs. Medicare reimbursement reform for providers including the Medicare Access and CHIP Reauthorization Act (MACRA). Medicare Part B Drug Reimbursement. FDA issues and Issues surrounding the tissue bank industry. HR 1190 and S. 141: Protecting Seniors' Access to Medicare Act (IPAB repeal). HR 2, the Medicare Patient Access and Quality Improvement Act (SGR reform). Implementation of The Breast Cancer Patient Education Act. HR 1221/S 626, the Helping Ensure Life- and Limb-Saving Access to Podiatric Physicians (HELLPP) Act. Training Tomorrows Doctors Today Act, and The Resident Physician Shortage Reduction Act. The Palliative Care and Hospice Education and Training Act. Issues and regulations governing the use and deployment of speech generating devices (SGDs) S.984 The Steve Gleason Act. Antibiotic Development to Advance Patient Treatment (ADAPT) Act. The 21st Century Cures Act, HR 6 and the Senate Innovations legislation. Ensuring Access to General Surgery Act - HR 4959. Draft legislation to reform the FDA's regulation of cosmetics. Provisions relating to combat surgical training and standards in the National Defense Authorization Act.
Client expense: Not reported · Firm income: $20,000